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X-ray crystallographyCytochrome c (Cc) and cytochrome c peroxidase (CcP) form a physiological complex in the inter-membrane
space of yeast mitochondria, where CcP reduces hydrogen peroxide to water using the electrons provided by
ferrous Cc. The Cc–CcP system has been a popular choice of study of interprotein biological electron transfer
(ET) and in understanding dynamics within a protein–protein complex. In this review we have charted seven
decades of research beginning with the discovery of CcP and leading to the latest functional and structural
work, which has clariﬁed the mechanism of the intermolecular ET, addressed the putative functional role of a
low-afﬁnity binding site, and identiﬁed lowly-populated intermediates on the energy landscape of complex
formation. Despite the remarkable attention bestowed on this complex, a number of outstanding issues
remain to be settled on the way to a complete understanding of Cc–CcP interaction.32 2 629 1963.
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Yeast cytochrome c peroxidase (CcP; ferrocytochrome-c : hydrogen-
peroxide oxidoreductase, EC 1.11.1.5) was discovered in baker’s and
brewer’s yeasts in 1939 [1]. Originally thought to be a soluble oxidase
[1], CcP was soon realised to be a novel enzyme catalysing reduction of
hydrogen peroxide and requiring reduced cytochrome c (Cc) for its
activity [2]. Initial studies performed in the early 1960s established that
CcP-catalysed conversion of H2O2 to water requires two reducing
equivalents from ferrous Cc (Eq. (1)) and involves formation of Cc–CcP
protein complex [3–6].
H2O2 þ 2Cc2þ þ 2Hþ ¼ 2Cc3þ þ 2H2O ð1Þ
Since then, much effort has been devoted to elucidating the
catalytic mechanism of this ostensibly simple reaction and under-
standing the process of intermolecular electron transfer (ET) from Cc
to the active site of CcP. Despite enormous progress made over the
past seven decades of research (Fig. 1), several questions concerning
Cc–CcP complex formation and ET remain unanswered. Here we
discuss literature pertaining to Cc–CcP interaction, including the
papers published since 2002, the year of the latest comprehensive
review on the subject [7]. For further information on individual
proteins and a more detailed picture of earlier research on Cc–CcP
system, the reader is referred to an excellent review by Vitello andErman [7], a number of older works [8–10], and recent reviews on
evolutionary [11] and structural [12] aspects of heme peroxidases.
1.1. Cytochrome c
Discovered in 1925 by Keilin [13], Cc is a key component of the
eukaryotic respiratory chain, where it functions as an electron carrier
between the membrane-bound Cc reductase and Cc oxidase. In yeast,
Cc has other physiological partners, such as cytochrome b2 (also
known as lactate dehydrogenase) and CcP [10]. The primary sequence
of this protein, reported for more than 100 different species, is highly
conserved among eukaryotes [10]. Two Cc isoforms, iso-1 and iso-2,
are found in yeast, the former of which is much more widely studied
and is referred to as yCc in this work. yCc is a positively-charged
(pI=9.54), low molecular weight (12.7 kDa) protein, consisting of
108 amino-acids1 and the heme prosthetic group. The native or
recombinant protein can be readily expressed and puriﬁed from
Saccharomyces cerevisiae [14–16] or Escherichia coli [17], respectively.
Native yCc contains trimethylated lysine at position 72, a post-
translational modiﬁcation absent in the recombinant protein isolated
from E. coli.
Cc is nearly spherical in shape and is formed by ﬁveα-helices and a
short β-strand (Fig. 2A), an overall fold that is highly conserved across
the protein family [18]. Cc contains a c-type heme group that is
located near the N-terminus and is attached to the polypeptide chainnumbering used in this work is based on the sequence alignment
that generates a negative numbering for the ﬁrst ﬁve residues
Fig. 1. Cc–CcP research timeline. Selected milestones indicated.
Fig. 2. Three-dimensional structure of yCc. (A) Overall fold of the protein; the heme is
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canonical CXXCH sequence (Fig. 2B). The heme contains a low-spin
(S=½), six-coordinated iron that has two physiologically relevant
oxidation states, Fe(II) and Fe(III), and is diamagnetic in the ferrous
and paramagnetic in the ferric form. The coordination sphere consists
of four pyrrole nitrogens of the heme, the Nε2 atom of H18, and the Sδ
atom of M80. To date, a number of high-resolution X-ray and solution
NMR structures of cytochromes c from different species have been
reported [10].
Owing to highly conserved primary sequences (Fig. 3) and very
similar three-dimensional structures, several eukaryotic cytochromes –
in particular horse Cc (hCc) – have been extensively used as structural
and functionalmimicsof yCc. Formanyaspects ofCc–CcP chemistry, this
has proven to be a valid approach; however, the physiological partner
(yCc) and non-physiological binders (cytochromes from organisms
other than yeast) exhibit distinct differences in their interaction with
CcP (see Section 5). In this respect, the variation in charge distribution
(Fig. 3), resulting in a 2.4-fold difference in dipolemoments of yeast and
horse Cc,2 is particularly noteworthy, given the importance of
electrostatics in Cc–CcP interaction.
1.2. Cytochrome c peroxidase
Found in the intermembrane space of yeast mitochondria [19,20],
CcP is a negatively-charged (pI 5.55), moderately-sized (34.2 kDa)
protein consisting of 294 amino-acids and a non-covalently attached,
b-type heme. Native or recombinant CcP can be isolated in a high yield
from S. cerevisiae [21–23] or E. coli [24–27], respectively, and is the
ﬁrst heme enzyme for which a crystal structure was solved [28,29]. It
is a highly α-helical molecule of cylindrical shape (Fig. 4A), with the
heme group buried in a hydrophobic pocket within the protein and
coordinated by the Nε2 atom of H175, the only axial ligand to the
heme iron (Fig. 4B). The sixth coordination position, which remains
vacant or is occupied by a water molecule in the resting state of the
enzyme [30], is available for the binding of the peroxide substrate. In
the resting state, CcP heme contains a high-spin (S=5/2), paramag-
netic Fe(III) atom, which is oxidised to an Fe(IV)=O oxyferryl
intermediate during the catalytic cycle (see below). In addition, a low-
spin (S=½) form of CcP with six-coordinate iron, approximating the
ligation state of the enzymatic ferryl intermediate, can be prepared by
cyanide binding to the vacant coordination position [21,31].
1.3. Cc–CcP interaction
In this section, we give a short overview of the key discoveries that
have shaped Cc–CcP research over the past seven decades (Fig. 1) and2 The dipole moments of ferric yCc (μ=522.9 D) and hCc (μ=215.7 D) were
calculated with MacroDox 4.5.3 [123,204] at pH 7.0 I=0.1 M t=25 °C, using Tanford–
Kirkwood partial charge assignments for titratable groups [205]. The angle between
the two dipole vectors is 10°.outline the present state of affairs in this ﬁeld. Early work on Cc–CcP
complex, initially hampered by low yields and variable purity of CcP
preparations, greatly beneﬁted from the development of an efﬁcient
protocol that allowed isolation of a highly pure enzyme from
S. cerevisiae [21]. Availability of sufﬁcient amounts of both proteins
enabled detailed kinetic and equilibrium studies, which demonstrated
1:1 Cc–CcP binding [32], proposed formation of 2:1 Cc–CcP complexes
at low ionic strength [33], and reﬁned the kinetic mechanism of
peroxide reduction [5,6,34].
Now it is well established that the catalytic cycle consists of at least
three steps (Eqs. (2)–(4)): reaction of CcP with peroxide to form
Compound I (CpdI), an intermediate oxidised two equivalents above
the native CcP(Fe3+); one-electron reduction of CpdI by Cc(Fe2+) to
Compound II (CpdII); and subsequent reduction of CpdII by another
Cc(Fe2+) equivalent to regenerate the resting-state CcP(Fe3+)
enzyme [7].
CcPðFe3þÞ þ H2O2 ¼ CpdI þ H2O ð2Þ
CpdI þ CcðFe2þÞ ¼ CpdIIþ CcðFe3þÞ ð3Þ
CpdIIþ CcðFe2þÞ ¼ CcPðFe3þÞ þ CcðFe3þÞ ð4Þ
In CpdI the heme iron is oxidised to Fe(IV)=O oxyferryl group
[35,36] and the side chain of W191 is oxidised to a cationic indole
radical (W191+•) [37–39]. CpdII, a one-electron reduction product of
CpdI, contains either an Fe(IV)=O (CpdIIF) or W191+• (CpdIIR)
species, depending on experimental conditions [40,41]. The last twoshown in sticks, and the protein termini are indicated by the labels. (B) The view of the
heme binding site showing the axial ligands, H18 and M80 (bold labels), and two
cysteine residues, C14 and C17, covalently linked to the heme group; heme propionates
are indicated. The molecular coordinates of ferric yCc were taken from the PDB entry
2YCC [209]. Figs. 1 and 3 were generated with MOLSCRIPT [210].
Fig. 3.Multiple sequence alignment of several eukaryotic cytochromes c. Differences in charged residues are highlighted. Heme iron ligands are shown in bold. The sequence of Cc
from Candida krusei, a protein used extensively in the study of ET kinetics (Section 4.3.), was taken from ref. [211].
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from ferrous Cc. Since the pioneering studies in the early 1970s, most
of the research in Cc–CcP ﬁeld has been focused on understanding the
process of protein complex formation and unravelling themechanistic
details of the two ET steps.
As shown by a variety of experimental techniques, and conﬁrmed
by the crystal structure of Cc–CcP complex [42], the interaction
between Cc and CcP occurs with a 1:1 stoichiometry in a broad range
of experimental conditions. However, several reports demonstrated
formation of a 2:1 complex at low-ionic strength, with the binding of
the second Cc molecule 2–4 orders of magnitude weaker than that of
the ﬁrst [43–46]. Since then, location of the second Cc binding site on
the surface of CcP has been a matter of debate that has given rise to
two contrasting views on the Cc–CcP interaction. The ﬁrst concept
postulates a unique 1:1 protein complex with the high-afﬁnity Cc
binding site as seen in the crystal structure [42] and a second, much
weaker binding site in the 2:1 complex, with no interactions between
bound Cc molecules. Another hypothesis proposes multiple forms of
the 1:1 complex, with Cc bound to different locations on the surface of
CcP, and suggests that the protein–protein orientation seen in the
crystal structure represents only a sub-population of binding
geometries [9,47,48]. In this view, formation of a 2:1 complex is
inhibited by strong electrostatic repulsion between bound Cc
molecules.
The two binding models have engendered two different mecha-
nisms for the intermolecular ET between Cc and CcP. According to one
view – termed here “one-site ET” and propounded primarily by
Durham, Millett and co-workers (Section 4.2.) – the ET occurs only
from the Cc bound to the high-afﬁnity site as seen in the X-rayFig. 4. Three-dimensional structure of CcP. (A) Overall fold of the protein; the heme is
shown in sticks, and the protein termini are indicated by the labels. (B) The view of the
heme binding site showing the axial ligand, H175 (bold label), the catalytically important
W191, and D235 that forms stabilising hydrogen bonds with the latter two; for clarity,
only side-chain atoms of H175 are shown. The aromatic ring ofW191 is parallel to, and in
van der Waals contact with, the imidazole ring of H175. The ﬁgure has been generated
from the crystal structure of the resting-state CcP (PDB entry 1ZBY [201]).structure. This model assumes interaction between low- and high-
afﬁnity sites at low ionic strength, with Cc binding to the former
promoting Cc dissociation from the latter. An alternativemechanism –
dubbed here “two-sites ET” and proposed by Hoffman and colleagues
(Section 4.3.) – posits multiple forms of the ET active 1:1 complex and
postulates that the ET from the second, weakly bound Cc is faster than
that from the Cc bound to the high-afﬁnity site. In what follows, we
review experimental evidence for the two binding models and the
ensuing ETmechanisms and discuss recent developments in the study
of Cc–CcP complex.
2. Cc–CcP complex formation
2.1. Binary complex
The ﬁrst direct evidence for 1:1 Cc–CcP complex formation,
suggested by earlier kinetics studies [3–6], came from the work of
Nicholls and Mochan [32,34,49], who showed by analytical ultracen-
trifugation and size-exclusion chromatography that Cc binds to the
resting-state CcP and its CN- derivative (CcPCN) with equilibrium
dissociation constant (KD) of 20 μM in 55 mM sodium phosphate pH
7.0 at 25 °C [32]. The elution proﬁle of Cc–CcP complex on a gel-
ﬁltration column revealed the presence of free and bound proteins,
indicative of an association–dissociation equilibrium typical of a
reversible complex formation [49]. Further studies by a variety of
equilibrium techniques, including spectrophotometry [50], analytical
ultracentrifugation [51], ﬂuorescence quenching [52,53], afﬁnity
chromatography [54], potentiometry [46], nuclear magnetic reso-
nance (NMR) spectroscopy [55–59], and isothermal titration calo-
rimetry (ITC) [60–66], have conﬁrmed formation of a 1:1 complex of
CcP with both yeast and horse Cc. At pH 6.0 and 25 °C, the measured
dissociation constants of yCc–CcP and hCc–CcP complexes are in the
range of 0.01–72 μM (I=18–200 mM) and 0.23–500 μM (I=3.5–
200 mM), respectively (see Tables 2 and 3 in ref. [7]).
Several general conclusions can be made from these studies. First,
binding of both yCc and hCc to CcP becomes weaker with increasing
ionic strength, conﬁrming the importance of electrostatic forces in Cc–
CcP complex formation. Second, yCc binding to CcP is stronger than
that of hCc in the entire range of experimental conditions, suggesting
a clear binding preference for the physiological partner. This
preference and a higher turnover observed with yCc than any other
cytochrome [33] indicate a co-evolution of yCc and CcP, as was
suggested for eukaryotic Cc and Cc oxidase [67]. Third, a number of
studies show that, for both yeast and horse Cc, binding to CcP is
virtually independent of Cc reduction state [32,46,53,59,66], consis-
tent with Cc(Fe3+) product inhibition observed by kinetics [3,34]. This
ﬁnding runs contrary to the conclusion of Hake et al. [54], who
reported a 50-fold stronger binding of CcP to ferrous than ferric Cc
immobilised on a Sephadex column. As mentioned before [7,46], this
drastic difference in binding is most likely due to column matrix
3 yCc and CcP charges are, respectively, +6 and −4 at pH 6.0 as estimated from
protein titration curves [206,207].
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the CcP spin-state [32,55,57,68], with both yeast and horse Cc binding
equally well to a high-spin, resting state CcP or a low-spin CcPCN
derivative [32,57]. Given that CcPCN is considered a good mimic of
Fe(IV)=O oxyferryl species in CpdI and CpdIIF intermediates
[57,69], this seems to suggest that, as far as “one-site” ET model is
concerned, both ET steps (Eqs. (3) and (4)) take place in Cc-CcP
complexes of the same binding afﬁnity.
2.2. Ternary complex
Formation of a ternary Cc–CcP complex was ﬁrst proposed in 1977
by Margoliash and co-workers to explain biphasic steady-state
kinetics curves and gel-ﬁltration proﬁles observed for the interaction
of CcP with horse and iso-2-yeast Cc [33]. However, soon afterwards it
was shown that the kinetics data could be explained equally well by
an independent, stepwise binding of two Cc molecules to a single,
catalytically-active site on CcP [70], and it was argued that the
accompanying size-exclusion experiments overestimated the amount
of bound Cc [7,50]. A related study of CcP interaction with iron-free
porphyrin derivative of hCc by ﬂuorescence quenching and analytical
gel-ﬁltration also suggested the presence of higher-order complexes
at low ionic strength [71]. Yet it too suffered from a number of
experimental drawbacks such as likely matrix effects on a Sephadex
column (run at I=4.2 mM) and a possible nonspeciﬁc binding of CcP
by the surface-active porphyrin Cc.
The ﬁrst conclusive evidence for 2:1 Cc–CcP complex formation
came from studies of Hoffman and co-workers [43–45], who followed
triplet-state quenching of Zn-substituted CcP or Cc by varying
concentrations of the respective redox partner in the Fe(III) state.
The observed, rather complex, kinetics are well explained by a model
postulating two non-interacting Cc binding sites of markedly different
afﬁnities and reactivities, with faster ET from Cc bound at the low-
afﬁnity site (see Section 4.3.). Shortly afterwards, Mauk et al. [46]
directly detected formation of a 2:1 yCc-CcP complex using potentio-
metry, a non-kinetic, equilibrium technique. The proton titration
curves ﬁt well to 1:1 and 2:1 binding models at I≥100 mM and
I≤50 mM, respectively, with ca. 1,000-fold difference in the binding
constants for the low- and high-afﬁnity sites at I=50 mM pH 6.0
25 °C. Interestingly, Cc binding to the high afﬁnity site is accompanied
by proton release, while Cc interaction at the low-afﬁnity site triggers
proton uptake, suggesting different electrostatic properties of the two
binding domains [46].
An ITC study by Leesch et al. [63], carried out in 10 mM phosphate
at pH 7.0 and 25 °C, has provided another indication for the presence
of a ternary hCc–CcP complex. However, the heat changes attributed
to the binding of the second Cc molecule were very small, so that no
reliable thermodynamic parameters for the binding to the low-afﬁnity
site could be obtained. From this limited experimental dataset, the
authors estimated Kd≥0.2 mM for the low-afﬁnity site and suggested
a negative binding cooperativity between two Cc molecules, with an
estimated ΔG penalty of 0.8 kcal/mol for the second binding event
[63]. Finally, another ITC study has demonstrated that the tri-
saccharides melezitose and rafﬁnose promoted formation of a 2:1
complex between yCc and CcP at I=50 mM pH 6.0 25 °C [72]. Given
that addition of mono-, di- and tetrasaccharides has virtually no effect
on Cc–CcP binding [65], the observed stabilisation of the ternary
complex is most likely due to speciﬁc interactions of the studied
trisaccharides with Cc and/or CcP, rather than crowding effects
suggested by the authors.
2.3. Localising Cc–CcP binding domains
2.3.1. Chemical modiﬁcation and early cross-linking studies
Early on it was established that electrostatics play a predominant
role in Cc–CcP interaction [3,49,73], as would be expected fromoppositely-charged molecules.3 In particular, it was shown that the
reaction is inhibited by polycations such as salmine [3] and polylysine
[73], both of which act as competitive inhibitors of Cc binding. In
addition, it was observed that polyacetylation, but not polyguanidina-
tion, of Cc lysines impaired its binding to CcP and abolished the
catalytic activity, highlighting the importance of the positive charge
on Cc, rather than Lys residues as such [73]. These ﬁndings
rationalised the observed ionic strength dependence of catalytic
peroxide reduction by the Cc–CcP pair [6,34]. More recent work has
illustrated that Cc–CcP binding can also be abolished by small
polylysine peptides [74] and functionalised charged nanoparticles
[75].
Complex formation between Cc and CcP was shown to inhibit
ascorbate reduction [76] of and cyanide binding [77] to Cc(Fe3+) and
have no effect on the binding of hydrogen peroxide and ﬂuoride to CcP
[77]. These results suggested that the exposed heme edge of Cc is
buried in the interface of the protein complex and Cc binding does not
occlude the channel leading to the active site of CcP. This agreed with
the previous NMR work of Gupta and Yonetani [55], and later Erman
and co-workers [56–58], who showed that the heme methyls of Cc
exhibit large spectral changes upon binding to CcP. Using an
ingeniously simple experiment, Gupta and Yonetani [55] estimated
the distance between the heme groups in hCc-CcP complex. The
authors reasoned that, if the two groups were close, changes in the
spin-state of CcP heme iron – effected by addition of CN- or F- ligands
to the resting-state enzyme and leading to drastic changes in
paramagnetic properties of Fe3+ atom –would affect NMR resonances
of hCc heme methyls. As no such effects were observed, the authors
concluded that the two heme groups must be separated by at least
25 Å [55].
In a pioneering chemical modiﬁcation approach, Margoliash and
co-workers used hCc modiﬁed with carboxydinitrophenyl and
trinitrophenyl groups at speciﬁc lysine residues as a probe of the
interaction with CcP [78]. They found that modiﬁcation of residues 13,
27, 72, 86, and 87 resulted in large changes in the observed kinetics
parameters, while alteration of lysines 8, 25, and 73 had little effect.
The authors concluded that the former group of residues, located at
the front face of hCc surrounding the exposed heme edge, deﬁnes the
CcP binding interface, while the latter three lysines sit at the
periphery. In addition to mapping out the hCc region involved in
CcP binding, this study established that “… the net charge of a
particular region and not of the entire molecule, is the major
parameter [in the interaction of Cc with CcP]” [78]. The main
conclusions of this work were conﬁrmed in a related study by Smith
and Millett [79], who showed that triﬂuoroacetylation of hCc lysines
13, 25, 79, and 87 decreased the reaction rate with CcP, while that of
22, 55, 88, and 99 did not.
Recognising the importance of electrostatic interactions in the
protein complex formation, and inspired by a similar approach used
for the redox pair of Cc and cytochrome b5 [80], Poulos and Kraut
constructed a model of Cc–CcP complex by visual optimisation of the
complementary charges on the two proteins [81]. Starting from
available X-ray structures of tuna Cc [82] and yeast CcP [29], the
authors matched a patch of aspartate residues on CcP with a ring of
lysines surrounding the exposed heme edge of Cc. The resultingmodel
exhibited ﬁve complementary charge interactions and two additional
hydrogen bonds across the interface (K13, K27, K72, K86, K87, Q12,
Q16 of Cc with D37, D79, D216, D37, D34, N87, and Q86 of CcP,
respectively), a remarkable steric ﬁt of the two proteins, and an
unexpected coplanarity of the two heme groups [81]. The Cc–CcP
binding model agreed well with the results of the earlier chemical
modiﬁcation study [78], and the separation between heme groups
was found to be in the range of the experimentally-determined heme-
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experimental studies aiming to validate the hypothetic model and
assess the role of the proposed interacting residues in the complex
formation.
Further chemical modiﬁcation work conﬁrmed the importance of
hCc residue K13 [83] and indicated a possible involvement of CcP
residue H181 [84] in the interaction with the binding partner.
Modiﬁcation of CcP carboxylate groups with carbodiimide reagent
was found to inhibit peroxidase activity, while acetylation of CcP
lysines showed little effect, once again demonstrating the signiﬁcance
of the negative charge on CcP [85]. When the reaction with
carbodiimide was carried out in the presence of hCc, a number of
CcP glutamates and aspartates became protected [86]. These residues
mapped out to two regions on the CcP surface: a negatively-charged
patch at the front face of the molecule (harbouring D33, D34, E35,
D37, E290, E291 and the C-terminal carboxylate of L294) and a pair of
E221 and D224, located towards the bottom (Fig. 5). The authors
noted that “Since cytochrome c is a globular protein of considerably
smaller size than cytochrome c peroxidase it is impossible for a single
molecule of cytochrome c to shield at once all of the above carboxyl
groups.” [86] An important conclusion from this work is that the
interaction between Cc and CcP appears to involve a broader binding
surface, rather than a single binding geometry implied in Poulos and
Kraut's model.
In an approach complementary to the chemical modiﬁcation
strategies discussed above, several groups attempted to “freeze-in”
the reactive Cc-CcP complex by chemical cross-linking [83,85,87–89].
Thus, Bisson and Capaldi [83] prepared hCc derivatives modiﬁed with
a photoactivatable arylazido group at speciﬁc lysine residues. Upon
addition of the binding partner and subsequent photo-activation, hCc
residue K13 became cross-linked to CcP residue(s) located in 50
amino acid-long N-terminal stretch as established by chemical
cleavage peptide mapping. The resulting cross-link exhibited no
peroxidase activity towards exogenously added Cc, indicating that
functional Cc binding site was blocked. Similar experiments with hCc
modiﬁed at K22, located at the back of the protein, yielded no
intermolecular products, conﬁrming the speciﬁcity of the Cc–CcP
interaction [83]. Using a water-soluble carbodiimide derivative – EDC,
a “zero-length” cross-linker promoting amide bond formation
between amino and carboxyl sidechains – Bosshard and co-workers
prepared covalent hCc-CcP complexes of 1:1 stoichiometry [85,87,89].
Peptide mapping of the puriﬁed product showed the presence of two
major cross-links, those of hCc K13 or K86 linked to CcP acidic
residues in 32–37 region. Using a similar, slightly modiﬁed, cross-
linking procedure [90], Erman and co-workers isolated a single,
covalent hCc–CcP product and showed that NMR spectral changes
exhibited by heme groups of both Cc and CcP in the cross-link are
identical to those observed in the native, non-covalent complex,
conﬁrming the validity of the cross-linking approach [90,91]. ManyFig. 5. A sketch of CcP structure showing the location of carboxyl groups protected from
chemical modiﬁcation in the complex with hCc. The arrow indicates the entrance to the
heme cleft. The black dot indicates the approximate location of His 181. The ﬁgure is
reproduced from ref. [86] with permission from the Journal of Biological Chemistry.early cross-linking studies reported certain heterogeneity of the
products [85,87–89], corroborated by subsequent kinetics [92] and
NMR [91,93] analyses, suggesting that more than one binding
geometry might be sampled in the course of Cc–CcP interaction.
Interestingly, comparison of the cross-linked products of CcP with hCc
and yCc by NMR revealed larger structural heterogeneity in the latter
[91,93], once again demonstrating clear species-speciﬁc differences in
Cc–CcP interaction (see Section 5). In addition, higher yields of yCc–
CcP cross-links at high rather than low ionic strength and exactly the
opposite observation for hCc–CcP covalent products were interpreted
as evidence for a larger impact of intermolecular electrostatic forces in
hCc–CcP complex formation [91].
2.3.2. X-ray crystallography
Suggested back in 1971 by Nicholls and Mochan [32], co-crystal-
lisation and X-ray structure determination of Cc–CcP complex were at
ﬁrst unsuccessful [94]. However, several years after, Pelletier and
Kraut [42] succeeded in solving crystal structures of both yCc–CcP and
hCc–CcP 1:1 complexes (Fig. 6). Contrary to an earlier electrostatic
model [81] and Brownian dynamics simulations [47,48] that predicted
numerous strong interactions across the interface, only two inter-
molecular salt bridges and a hydrogen bond (K8-N38, K72-E290, and
K87-E35; Cc residues given ﬁrst) were observed in hCc–CcP structure
(Fig. 6A). Remarkably, a sole, weak intermolecular hydrogen bond
(N70-E290, Cc residue given ﬁrst) mediates protein–protein interac-
tion in yCc–CcP complex (Fig. 6B). Both complexes appear to be
stabilised mainly by overall electrostatic potential of the protein
molecules and van derWaals interactions [42]. Noticing that the heme
group of yCc is in van der Waals contact with the CcP surface, Pelletier
and Kraut proposed an ET pathway, which would require a single,
through-space electron jump from Cc heme to A194 or A193 residue
of CcP, followed by a through-bond travel via an A193-G192-W191
conduit (Fig. 6D). In contrast, the closest distance between hCc heme
and CcP is 7 Å, rendering direct ET from the crystallographic
orientation inefﬁcient (Fig. 6C). The authors suggested that weaken-
ing of the intermolecular charge–charge interactions (e.g. at higher
ionic strength), followed by subtle re-orientation of hCc molecule
could bring it into a favourable ET arrangement, similar to that of yCc–
CcP [42]. Heme-to-heme distances in the two crystallographic
complexes are compared to those determined in earlier solution
studies in Table 1.
To solve hCc–CcP structure, Pelletier and Kraut partially dehy-
drated protein crystals before data collection, an idiosyncrasy found to
improve X-ray diffraction [42] but raising concerns that the
accompanying changes in protein hydration might force the mole-
cules into a “non-native” orientation [9]. This contentious issue has
been settled by Crane and co-workers [96], who solved the X-ray
structure of hCc complex with Zn-substituted CcP (ZnCcP) using ‘wet’
crystals, showing that the two structures are virtually identical. To
date, a number of Cc-CcP structures have been reported (Table 2); all
of them exhibit small, poorly packed, rather hydrophilic binding
interfaces, typical of transient complexes of redox proteins [103]. In
order to assess whether the crystallographic Cc–CcP orientation is
representative of the binding geometry in solution, Crane and co-
workers [96] compared triplet state quenching of ZnCcP by Cc in
crystal and solution (see Section 4.3). The authors found a remarkably
close match between the quenching constants, concluding that crystal
and solution structures must be the same. This ﬁnding was
independently conﬁrmed by an NMR study, which showed that
crystallographic yCc–CcP orientation is indeed the dominant form of
the complex in solution [100].
In retrospect, Poulos and Kraut's model [81] appears over-
optimised: snug steric ﬁt of two proteins and seven hydrogen bonds
across the interface would greatly reduce the dissociation rate
constant (koff), effectively limiting enzyme turnover. Comparison of
this hypothetical model with the X-ray structures of the complex
Fig. 6. Crystallographic structures of (A, C) hCc–CcP and (B, D) yCc–CcP complexes. (A, B) Cc and CcP are coloured yellow and light-blue, respectively. Heme groups are shown as
sticks. Residues forming intermolecular hydrogen bonds are shown as sticks and indicated by labels. (C, D) Proposed ET pathway in CcP complexes with hCc (C) and yCc (D). The
ﬁgure was prepared from PDB entries 2PCB and 2PCC [42] using PyMOL [212].
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nature's pragmatism: the former strived to optimise the binding,
while the latter balanced the need for high afﬁnity and fast
dissociation, ultimately optimising for efﬁciency. The ground breaking
work of Pelletier and Kraut [42] paved the way for subsequent studies
of the Cc–CcP structure–function relationship by the combination of
site-directed mutagenesis and biophysical techniques.
2.3.3. Site-directed mutagenesis
Since the preparation of the ﬁrst, site-speciﬁc CcP mutants in
S. cerevisiae [22] and E. coli [104], a number of variant Cc–CcP
complexes have been investigated. Corin and co-workers [54,105,106]
studied the effects of charge-reversal D37K, D79K, and D217K CcP
mutations on the interaction with yeast and horse Cc by a
combination of kinetic and equilibrium techniques. They showed
that substitution of CcP D37 residue, sitting close to the crystallo-
graphic binding site, leads to destabilisation of Cc–CcP complexes,
while mutation of the latter two aspartates – located further away on
CcP surface – have little effect. In a series of works, Millett and co-
workers [107–110] studied the interaction of horse and yeast Cc with
E32Q, D34N, E35Q, E290N, E291Q, and A193F CcP variants, designed
speciﬁcally to probe the crystallographic binding domain. Using
stopped-ﬂow kinetics and photo-induced ET measurements, the
authors demonstrated that CcP residues D34, E35, A193, and E290
(but not E32 and E291) are involved in Cc–CcP complex formation, inTable 1
Experimentally-determined heme-to-heme distances in Cc–CcP complexes. When
applicable, Fe–Fe distances are given in parentheses.
Distance, Å Complex Method
N25 hCc–CcP NMR [55]
14.9±0.5 yCc–CcP FRET [52]
7 (17.5±2.5) hCc–CcP? Excitation spectroscopy [95]
23.5±0.5 yCc–CcP FRET [71]
19.1 (26.5) yCc–CcP X-ray [42]
22.4 (30.0) hCc–CcP X-ray [42]good agreement with X-ray work [42]. These ﬁndings were conﬁrmed
in an ITC study of Erman et al. [61], who detected a 3–4 fold decrease
in hCc afﬁnity for D34N, E32Q, E35Q, A193F, and E290N CcP (all
residues located within Cc binding site), but not its E291Q variant
(sitting at the periphery, with the sidechain pointing away from the
bound Cc). The observed effects and the accompanying changes in
thermodynamic parameters agreed well with the X-ray structure of
hCc–CcP complex [42].
Pielak andWang [64] also used ITC to investigate the binding of the
wild-type (wt), A81G, K72A, and K87A yCc to CcP D34A, V197A, and
E290A mutants to probe the high-afﬁnity, crystallographic site; and
wt yCc interaction with D148A, D217A, and L182A CcP to explore
secondary Cc binding regions. The authors found: 1) a modest, 1.7 to
4-fold decrease in CcP binding afﬁnity for K72A and K87A yCc
variants; 2) little inﬂuence of CcP mutations designed to interrogate
non-crystallographic binding sites; 3) large (ΔΔGN2 kcal/mol) effects
of V197A and E290A CcP substitutions4; and 4) surprising, stabilising
effect of D34A CcPmutation, leading to a 4-fold increase in the binding
constant. Given the central location of D34 residue in the yCc-CcP
interface as seen in X-ray structure [42] and considering the
destabilising effect of D34N mutation in hCc–CcP complex [61], the
underlying structural causes of enhanced D34A CcP–yCc binding
remain unclear [7]. Furthermore, using double-mutant cycles, Pielak
andWang discovered a stabilising interaction between Cc A81 and CcP
V197 sidechains (coupling energy ΔΔGc=−1.9±0.7 kcal·mol−1)
[64], in excellent agreement with X-ray structure showing multiple
van der Waals contacts between the two residues [42].
In an impressive experimental effort, Erman and co-workers
[111,112] prepared 46 charge-reversal CcP variants, mutating each of
the 20 glutamates and 24 out of 25 aspartates to lysine residues and
introducing two positive-to-negative R31E and K149D substitutions,4 The reported value of ΔG=−1.9±0.2 kcal/mol, translating into ca. 35,000-fold
decrease in the binding afﬁnity relative to the wt complex, is most likely erroneous;
see [7] for details.
Table 2
Summary of the Cc–CcP structures deposited in the Protein Data Bank at the time of writing. The interface analysis was performed with ProtorP [102]. For structures containing two
complexes in the asymmetric unit, the averages of the values calculated for both individual complexes are given.
PDB entry Complex Resolution (Å) RMSD (Å)a Interface size (Å2)b % Buried surfacec Interface polarityd Gap index (Å)e Ref
2PCC yCc–CcP 2.3 0.63f 1107 47/46 37/47 4.9 [42]
2PCB hCc–CcP 2.8 6.60g 1030 50/49 61/58 5.3 [42]
1U74 yCc–ZnCcP 2.4 0.58 1170 54/53 39/45 4.8 [96]
1U75 hCc–ZnCcP 2.55 0.67 1126 49/47 59/55 4.1 [96]
1S6V A81C yCc–V197C CcP covalent crosslink 1.88 2.82 569 26/25 21/34 11.5 [97]
2B10 F82S yCc–ZnCcP 2.8 0.96 1292 56/56 40/49 3.9 [98]
2B11 F82W yCc–ZnCcP 2.3 0.52 1150 52/52 40/46 4.8 [98]
2B12 F82Y yCc–ZnCcP 3.02 19.02 757 32/33 43/30 7.7 [98]
2B0Z F82I yCc–ZnCcP 2.7 18.94 825 37/41 44/40 5.6 [98]
2BCN yCc–ZnCcPh 1.7 0.75 1185 51/48 44/42 5.1 [99]
23.34 593 26/26 45/52 9.1
2GB8 yCc–CcP N/Ai 2.02 1320 58/52 35/46 4.5 [100]
2JTI T12A yCc–CcP N/Ai 1.50 1445 65/68 39/48 3.6 [101]
a Root mean square deviation calculated for Cc Cα atoms after superimposition of CcP molecules in the query and the corresponding yCc-CcP or hCc-CcP Pelletier and Kraut
structure.
b Interface size, deﬁned as the sum of accessible surface areas (ASA) buried by two proteins upon complex formation.
c Percent of ASA buried by each protein in the complex; Cc values are given ﬁrst.
d The percentage of the interface area composed of polar atoms; Cc values are given ﬁrst.
e Gap index is deﬁned as the gap volume, a volume of the empty space between interfacial atoms, divided by the interface size.
f Calculated between two complexes in the asymmetric unit.
g Calculated with 2PCC structure as a reference.
h The asymmetric unit of this structure, solved in D2O, contains 1 Cc and 2 CcP molecules, forming two intermolecular interfaces.
i Backbone-resolution structures solved by solution NMR. All values are calculated for the ﬁrst model in the ensemble.
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kinetics, the authors found that only 5 out of 46 CcP mutants (R31E,
D34K, D37K, E118K, and E290K) exhibited reduced afﬁnity for the
binding partner, in agreement with earlier mutagenesis studies
[54,61,105,106]. Four of the affected residues are located within,
and the other one near, the crystallographic binding site, strength-
ening the argument that CcP posses a single, catalytically active Cc
binding domain— that observed in the X-ray structure of the complex.
Studies of CcP interaction with Cc mutants established the relative
unimportance of a highly-conserved yCc residue K27 (K32 according
to the numbering system used in that work) [113] and conﬁrmed a
central role of F82 [98], mediating Cc–CcP interaction as seen by X-ray
[42] and NMR [59,93] and known to control the intermolecular ET
[114,115]. Another work demonstrated that alanine substitution of
yCc residues R13 and T12, two more sidechains located in the Cc–CcP
interface, led to a 30-fold decrease and a 10-fold increase in CcP
binding afﬁnity, respectively [66]. Just as in the case of the D34A CcP
mutation discussed above [64], structural determinants of the tighter
binding in T12A Cc-CcP complex are not known. Using double-mutant
cycles, Volkov et al. [66] showed that Cc R13 interacts with Y39
residue of CcP, in agreement with the crystal structure of the complex
[42] exhibiting van der Waals contacts between the two sidechains.
Given their central location in Cc–CcP interface and large effects of
their alanine substitutions on the binding energetics, the authors
proposed that Cc R13 and CcP Y39 are part of a binding ‘hot spot’ [66].2.3.4. Localising low-afﬁnity binding site
Experimental localisation of a secondary Cc binding site(s) on the
surface of CcP has been exceedingly hard due to a large difference in
the binding constants for the low- and high-afﬁnity sites (103–104-
fold, see Section 2.2), complicating detection of the former in the
presence of the latter. So far, only two studies have risen to this
difﬁcult task. Both of them used mutagenesis to assess the role of CcP
residues located in a negatively-charged region identiﬁed as a
secondary Cc binding site in Brownian dynamics simulations
(discussed in detail in Section 3.1) [47,48]. Using ITC and triplet
state quenching of ZnCcP by hCc, Leesch et al. [63] showed that the
charge-reversal K149E CcP mutation leads to ca. 10-fold increase in Cc
binding to the low-afﬁnity site, while D148K substitution has littleeffect. Given the proximity of the two residues and the central
location of D148 in the putative binding site, the latter ﬁnding is
difﬁcult to rationalise. In contrast, in their ITC study of a 2 : 1 yCc–CcP
complex stabilised by trisaccharide melezitose, Morar and Pielak [72]
conclusively demonstrated that D148A mutation of CcP abolishes
ternary complex formation. Taken together, these results suggest that
CcP residues D148 and K149 deﬁne the low-afﬁnity Cc binding site.
3. Dynamics in Cc–CcP interaction
It is generally agreed that, except for sidechain reorganisation at
the binding interface, Cc–CcP complex formation does not lead to
conformational changes of individual proteins as evidenced by
analytical ultracentrifugation [49], X-ray crystallography [42,96], and
NMR spectroscopy [59]. However, small binding-induced perturba-
tions of the CcP heme environment were observed by high-resolution
ﬂuorescence [116], UV-visible [74], NMR [57,69], and resonance
Raman [117] spectroscopies. As the CcP heme group is buried inside
the protein core, these ﬁndings indicate a certain conformational
ﬂexibility of the CcPmolecule and suggest a possibility that Cc binding
event is propagated to the enzyme's active site [69]. Still, the observed
effects are very small, so that formost practical purposes interacting Cc
and CcP can be treated as rigid-bodies. In this context, the dynamics
observed in Cc–CcP complex anddiscussed belowarise fromvariations
in relative orientations of protein molecules rather than binding-
induced structural changes of individual proteins.
3.1. Molecular modelling
Early availability of crystal structures of individual proteins and
the general agreement on the dominant role of electrostatics in Cc–
CcP interaction encouraged theoretical modelling of Cc–CcP complex.
Early on it was established that an asymmetric charge distribution on
the Cc molecule results in a large electric dipole moment, an
important determinant of Cc interaction with different partners
[118,119]. In particular, Koppenol and co-workers [119,120] showed
that changes in the dipole moment can explain differences in
reactivities of various hCc lysine derivatives towards CcP [78]
(Section 2.3.1), and coarse-grained Brownian dynamics (BD)
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dipole-induced electrostatic torques in accelerating Cc–CcP associa-
tion to the experimentally observed values.
Extending these ideas further, Northrup and co-workers [47,48]
performed detailed BD simulations of hCc–CcP complex employing
atomic-resolution protein structures, the Poisson–Boltzmann equa-
tion to calculate electrostatic interaction potentials, and realistic
reaction criteria based on heme-to-heme distances (d) and angles (ϕ).
The analysis of the BD trajectories – leading from fully separated
protein molecules to formation of Cc–CcP encounters and subsequent
dissociation or conversion to a reactive protein complex – provided
information on possible binding geometries and probabilities of the
productive encounters, which could be further converted into the
association rates (kon). Several important conclusions came from this
work. First, instead of converging to a single, unique solution, the
simulations produced a large ensemble of electrostatically favourable
encounter complexes, predominantly localised in three CcP regions:
Site 1, clustered around D34 and containing the crystallographic high-
afﬁnity Cc binding site; Site 2, centred on D148 and comprising ET-
competent docking geometries at the back of the protein; and Site 3,
or “D217 face” [47], connecting the latter two regions (Fig. 7A). Based
on this observation, the authors concluded that “… there is no
dominant complex which forms, but a surprisingly even distribution
over a variety of complexes” and “… there is a not [sic] strict chargeFig. 7.Molecular modelling of Cc–CcP interaction. (A) BD simulations of Northrup et al.
[48]. The diagram shows Boltzmann-averaged total electrostatic potential energy of
interaction between CcP and hCc in units of kBT as a function of Cc centre of mass.
Reproduced with modiﬁcation from ref. [48] with permission from Science. (B) MC
simulations of yCc–CcP encounter complex [125]. Overall distribution of yCc molecules
is displayed as a reweighted atomic probability density map [213] (plotted at a
threshold of 0.5% maximum, blue). The CcP surface is coloured by the electrostatic
potential calculated at±5 kBT (red — negative, blue — positive) with APBS [214].
Reproduced from ref. [132] with permission from the Journal of Biomolecular NMR.complementarity in operation that locks the proteins into a single
electron transfer arrangement, but that association is more non-
speciﬁc in nature” [48]. Second, the analysis revealed that the
electrostatic stabilisation of Cc–CcP complexes was achieved by 2 to
4 intermolecular ionic contacts, conﬁrming the importance of certain
charged patches rather than the total protein charges. Third, the
authors noticed that “… cyt c undergoes numerous rotational
reorientations … as it explores an extensive region on the surface of
cyt c per[oxidase], and may even include all three major docking
regions in one excursion” [48]. This ﬁnding suggested a possible
communication between spatially separated CcP Sites 1 and 2, with
region 3 acting as an intervening conduit. Finally, analysis of the
simulated association rates revealed that a combination of the
contributions from both Sites 1 and 2 is required to reproduce
experimental kon values, suggesting a “… necessity for electron
transfer to occur from a range of electrostatically favourable
encounter geometries” [48]. Intriguingly, the best match with the
experimental kon was found for docking solutions with db20 Å and
ϕ=60°, the binding geometry observed later in the X-ray struc-
ture [42]. The general conclusions of Northrup et al. [47,48] were
conﬁrmed in a subsequent modelling study by Warwicker [122],
whose electrostatic energy maps revealed extensive hCc–CcP inter-
action surface, with Cc molecule experiencing considerable rotational
motion, again suggesting a ﬂexible binding interface, rather than a
single, static Cc–CcP complex.
BD simulations of yCc–CcP system [123,124] employed different
reaction criteria, namely intermolecular polar contacts in the
crystallographic complex, which provide accurate association rates
for the dominant binding geometry, but give no information on the
overall distribution of protein encounters as observed for hCc–CcP.
The simulated kon constants are in a good agreement with the
experimental values [123,124], suggesting that most of the ET can
occur from the high-afﬁnity Cc–CcP site as seen in the X-ray
structure [123]. Even with such restrictive reaction criteria, Gabdoul-
line and Wade [124] observed an extended distribution of yCc–CcP
encounters in the area surrounding the crystallographic binding site
and reported considerable rotational motion of the Cc molecule,
similar to what was seen for hCc–CcP system (see above). Recent
Monte Carlo (MC) simulations used atomic partial charges to calculate
Poisson–Boltzmann electrostatic potentials and a uniform distance
cut-off as a sole reaction criterion to generate an ensemble of yCc–CcP
encounters [125]. Overall, the encounter distribution is very similar to
that obtained for hCc-CcP complex by Northrup et al. [47,48] except
for a shallower D148 region (Fig. 7B), which can either be due to
differences in the simulation protocols or reﬂect species-speciﬁc
variation in Cc charge distribution.
3.2. Experimental evidence
The ﬁrst experimental evidence for dynamics in Cc–CcP complex
came from early chemical modiﬁcation and cross-linking studies
(Section 2.3.1.), which suggested that multiple binding geometries
might be sampled in the course of Cc–CcP interaction. This conclusion
was indirectly conﬁrmed by crystallographic study of Poulos et al.
[94], who showed that electron density maps of hCc–CcP co-crystals
contain only CcP molecules, while hCc is orientationaly disordered
and occupies the space between CcP dimers. A possible explanation of
the observed results proposed that the interaction between the two
proteins occurs over a broad binding surface, leading to dynamic
disorder of hCc molecules.
In their studies of time-resolved ﬂuorescence resonance energy
transfer (FRET) between Mg-substituted CcP (MgCcP, donor) and Cc
(acceptor), McLendon and co-workers [126,127] found a striking
difference between FRET decay curves obtained at 300 K and 77 K.
While the former showed a simple, monoexponential behaviour, the
latter exhibited far greater complexity and required at least three
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indicates a distribution of decay times arising from a distribution of
donor-acceptor distances, which implies the presence of multiple
protein–protein orientations, each of which will have a characteristic
donor-acceptor distance and angle and, thus, a characteristic energy
transfer rate [126]. Analysis of the decay curves provided a
distribution of donor-acceptor separations in yCc–CcP system
(Fig. 8), which agrees well with heme-to-heme distances determined
in other studies (Table 1). As noted by the authors, at 77 K “the
distribution of protein complexes would be frozen out and could not
rearrange on the time scale of ﬂuorescence (10−8 s)”, while at 300 K
“small amplitude motions at the interface would allow these
conformers to equilibrate. If equilibration occurred on nanosecond
time scale, the distributed kinetics found at low temperatures would
be largely or completely washed out.” [127] Thus, this work presented
a picture of a dynamic protein complex consisting of multiple, rapidly
interconverting protein–protein orientations of similar binding
energies, which became a basis of McLendon's “Velcro” model [128]
for the interaction between redox proteins.
Subsequent studies of hCc–CcP [129] and yCc–CcP [130] in-
teractions by hydrogen-deuterium exchange NMR spectroscopy
revealed large protection factors for the residues localised on the
front face of Cc, consistent with complexes' crystallographic struc-
tures [42]. However, a number of Cc residues located at the back of the
molecule also became protected, indicating considerable mobility of
the bound Cc. Furthermore, the protection factors for hCc–CcP
complex were very small [129], which was taken as an additional
evidence for a dynamic interaction. From comparison of the predicted
and observed protection factors, Jeng et al. [129] estimated that the
crystallographic hCc-CcP binding region must be cleared for 25–40%
of the lifetime of the complex. In another NMR study, Moore et al.
[131] probed the binding of CcP to Nε,Nε-13 C-dimethyl lysine
derivatives of yCc and hCc by two-dimensional [1H, 13 C] COSY
spectroscopy. It was found that at least 6 (yCc) or 7 (hCc) lysine
residues were involved in the interaction with CcP, which was
interpreted as an evidence for the multiple binding geometries in Cc-
CcP complexes. Unfortunately, only 3 yCc dimethyl lysine resonances,
and none for hCc, could be unambiguously assigned, precluding
detailed analysis of the observed binding effects.
3.2.1. PRE NMR spectroscopy
Very recently, the extent of dynamics in yCc–CcP complex was
quantiﬁed by paramagnetic relaxation enhancement (PRE) NMR
spectroscopy [100,101,125,132]. PRE is caused by magnetic dipolar
interactions between a nucleus and an unpaired electron of a
paramagnetic probe [133,134], which can be introduced into the
molecular frame by bioconjugation techniques. Due to the largeFig. 8. The distribution of MgCcP–Cc donor-acceptor distances obtained by FRET at 77 K.
The data taken from ref. [126].magnetic moment of the unpaired electron and r− 6 distance
dependence, protein nuclei located close to the paramagnetic centre
experience very large PREs, so that even lowly-populated species can
give rise to a measurable effect. For protein complexes in the fast
exchange regime, themeasured PRE is a population-weighted average
of the contributions from all protein-protein orientations and, as such,
contains the information on both the speciﬁc binding form and the
encounter state [133].
In order to map out the conformational space explored by the
interacting yCc and CcPmolecules, a paramagnetic spin-label (SL) was
introduced to 10 different locations, one at a time, on the surface of
CcP via an engineered cysteine residue (Fig. 9A), and intermolecular
PRE effects on Cc nuclei were measured. Three SLs located close to the
crystallographic binding site (N38C, N200C and T288C, shown as red
spheres in Fig. 9A) gave rise to PREs, while SLs attached to any of the
other seven positions (blue spheres in Fig. 9A) showed no effects
[100,125]. Most of the observed PREs (Γ2) arise from the dominant
form of yCc–CcP complex (Fig. 9B, N200 proﬁle) and can be used to
calculate the structure of the complex in solution [100]. However,
several Cc regions experience additional paramagnetic effects
(highlighted in Fig. 9B). As the experiments were performed in
conditions precluding formation of a 2:1 Cc–CcP complex
(I=125 mM), the additional PREs (Γ2*) contain no contribution
from Cc bound to the low-afﬁnity site, but rather originate from
protein-protein orientations constituting the encounter state [100].
Most of Γ2* map out to the N- and C-terminal Cc helices (Fig. 9B). The
latter region is similar to that exhibiting large protection factors in the
HD exchange study of Yi et al. [130] and experiencing chemical shift
perturbations (Δδ) upon binding to CcP [59]. However, no Γ2* effects
or signiﬁcant Δδ were observed for Cc W59 and N60 groups, two
residues showing large protection factors in the complex with CcP
[130].
Reﬁnement of the observed PREs (Γ2obs) against a simulated
ensemble of electrostatically-favourable protein–protein orientations
[125] provided an estimate for the population of the yCc–CcP
encounter state (p), which was subsequently conﬁrmed by an
independent analysis [132]. Thus, it was found that the proteins
spend 70% of the lifetime of the complex in the dominant orientation
as seen in the crystal structure [42] and 30% sampling multiple
binding geometries in the dynamic encounter state [125]. A related
study of variant Cc–CcP complexes demonstrated that p can be
modulated by interfacial point mutations [101]. In particular, it was
shown that R13A Cc mutation leads to a dramatic increase in the
population of the encounter state (p=80%), rendering it the
dominant form of the protein complex.
Knowledge of p allowed decomposition of Γ2obs for the wt complex
into the contributions from the dominant Cc–CcP form (Γ2dom) and the
encounter state (Γ2*), which was used to reﬁne the encounter
ensemble [132]. As can be judged from Γ2 plots in Fig. 9B, a
combination of PREs from the reﬁned ensemble and the dominant,
crystallographic orientation provides a good agreement with the
experimental data. In the encounter state, Cc explores an area of CcP
surface surrounding the high-afﬁnity, crystallographic binding site
(Fig. 9C), corresponding to themost favourable Cc–CcP binding region
in the classical BD simulations of Northrup et al. [48]. While sampling
multiple binding orientations, Cc undergoes a considerable rotational
motion, in agreement with earlier experimental [130,131] and
theoretical [48,122] studies. The encounter ensemble is characterised
by large separations between redox centres (Fig. 9D), indicating that
the overwhelming majority of protein-protein orientations constitut-
ing the encounter state are ET-inactive.
When compared to the results of earlier FRET work [126,127], the
heme-to-heme distance distribution obtained from PRE analysis
appears to be broader and shifted towards higher values (cf. Figs. 8
and 9D). Another, more puzzling, observation is that, contrary to PRE
NMR experiments that detect the encounter state at 300 K, FRET
Fig. 9. PRE NMR analysis of Cc–CcP interaction. (A) Crystallographic yCc–CcP binding orientation [42]. Cc and CcP are in yellow and grey, with heme groups in sticks. Cα atoms of CcP
residues used for spin-labelling are shown as spheres, coloured according to whether the attached SL exhibits intermolecular PREs (red) or not (blue). One SL position (K97, blue) is
not seen in this view. (B) Observed and calculated PREs for Cc–CcP–SL complexes. Experimental Γ2obs (black) [100,125], Γ2dom for the speciﬁc orientation (blue), and Γ2tot for the
combination of the speciﬁc form and an encounter ensemble (red). Crosses indicate the values of Γ2≥125 s−1 for the calculated PREs or identify the residues whose resonances
disappear in the paramagnetic spectrum. The errors are standard deviations. For SLs attached at positions N38 and T288, only Cc regions exhibiting encounter PREs are shown.
(C) Reweighted atomic probability density maps for the overall distribution of Cc molecules obtained from 100 PRE-based ensemble calculations (plotted at a threshold of 20%
maximum). For each SL position, an ensemble of orientations used for averaging is shown. The low-density patch of solutions at the back of CcP is a computational artefact arising
from an incomplete experimental coverage [132]. (D) Intermolecular ET donor-acceptor distances in the encounter state. Distributions of edge-to-edgeW191 (CcP)— heme (Cc) and
heme-heme distances are shown by yellow and grey bars, respectively. Orange and black curves are the corresponding Gaussian ﬁts with parameters xc=29.6±0.4 Å,
w=10.0±1.3 Å, r2=0.935 (heme-to-W191) and xc=30.9±0.4 Å, w=10.4±1.6 Å, r2=0.921 (heme-to-heme). Solid vertical lines mark the corresponding ET distances in the
speciﬁc complex. Panels (A)–(C) are reproduced with modiﬁcation from ref. [132] with permission from the Journal of Biomolecular NMR.
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would be expected for multiple protein-protein orientations
[126,127]. As Γ2 PREs are insensitive to fast dynamics (ps-ns
timescale) and report mainly on slower motional processes (μs-s
range) [134], the fact that encounter PREs could be readily detected
suggests that the accompanying dynamics are governed by the latter
timescale. Moreover, the lifetime of the encounter state (τ*) can be
calculated from its population (p=30%) and the lifetime of Cc-CcP
complex (τ), either measured directly (τ=1.5–2.5 ms) [58] or
estimated from the dissociation rate constant (τ=1/koff=0.8 ms)
[59]. The calculated value of τ*=250–750 μs indicates that the
encounter state dynamics occur on the timescale of a FRET
experiment and, given the broad distribution of donor-acceptor
distances (heme-to-heme data in Fig. 9D), should give rise to complex
FRET decay curves at 300 K. However, no such behaviour was
observed experimentally [126,127]. Together with the differences
between the distance distributions obtained by the two experimental
techniques, this apparent discrepancy can be due to differences in the
experimental conditions (in particular ionic strength, I=12 mM in
FRET work [126,127] and I=125 mM in PRE studies [100,125]) or a
possible perturbation of the ‘native’ Cc–CcP interaction by Mg-
substituted CcP used as a FRET donor.
4. Electron transfer in Cc–CcP complex
4.1. Historical perspective
The discovery of CcP in yeast [1,2] prompted comparisons with
plant peroxidases, such as horse radish peroxidase (HRP). Known for a
substantial time, HRP is a paradigm example of a prosthetic group-
dependent enzyme, speciﬁc for its peroxide substrate but much less
speciﬁc for the co-substrate reductant. In the ﬁrst published kinetic
comparison of CcP and HRP, Chance [135,136] identiﬁed the former asalways showing ﬁrst order kinetic behaviour (and hence a compar-
atively high apparent Michaelis constant, Km, or a weak afﬁnity for
Cc), whereas the HRP reaction obeyed zero order kinetics, suggesting
an intermediate role for an enzyme co-substrate complex.
Working on a mitochondrial Cc oxidase, Conrad and Smith [137]
unexpectedly discovered that the oxidation followed ﬁrst order
kinetics, even at Cc levels sufﬁcient to secure maximal turnover. The
explanation was that reduced (Cc(Fe2+), substrate) and oxidised (Cc
(Fe3+), product) Cc had the same binding afﬁnity for the enzyme,
indicating product inhibition by ferric Cc. Further, the authors
reasoned that if ferric Cc was inhibitory, then so was the ferrous
form. Thus, both bound forms of the enzyme were deemed inactive,
and the active species was free enzyme, which oxidised ferrous Cc in a
bimolecular ‘collision’ process. Beetlestone [3] adapted this model for
CcP. Assuming the inhibition by both ferric and ferrous Cc, the
behaviour in this kinetic model is still ‘Michaelian’, but the apparent
Km is actually the inhibition constant (Ki), while the apparent
maximal turnover is the product k·Ki, where k is the bimolecular
rate constant (in M−1 s−1). Were the inhibition to be eliminated, the
turnover would be much larger than the experimentally determined
maximal value. The proposed mechanism was hard to refute by any
simple kinetic analysis.
Clearly spelled out by Minnaert [138,139], alternative kinetic
models for Cc oxidase, especially those involving ‘active’ complexwith
ferrous Cc and product inhibition by ferric Cc, prompted a re-
examination of Cc oxidation by both HRP and CcP. Perhaps in the last
such attempt before the discovered complexities of the mitochondrial
oxidase made further parallel comparisons unfruitful, Nicholls [4,140]
compared both enzymes with Cc oxidase. Contrary to Chance, who
had postulated Cc binding to HRP but not CcP (see above), exactly the
opposite was found. In particular, it was shown that HRP formed no
complex with Cc, and its oxidation involved internal ET from either
oxyferryl or porphyrin π-cation radical in CpdI to a more surface-
1492 A.N. Volkov et al. / Biochimica et Biophysica Acta 1807 (2011) 1482–1503located site, accessible to a large co-substrate molecule like Cc. In
contrast, CcP, like Cc oxidase, seemed to form an ‘active’ complex with
ferrous Cc and an inactive one with the ferric protein. However, the
identiﬁcation of the kinetic intermediate with any stable complex
formed between the two ferric proteins in the absence of peroxide
remained to be demonstrated.
After his fundamentalwork on Cc oxidase, Yonetani [21] developed
a new procedure for isolating yeast CcP, which gave a product with
much higher activity than that obtained by the original method of
Altschul and co-workers [2]. Yonetani identiﬁed the initial product of
the reactionwithperoxide as a trueMichaelis complex, complexES [5].
Analogies with both myoglobin and non-speciﬁc peroxidases indicat-
ed that this intermediate had to be amixed oxyferryl/radical species, in
which the radical was much more stable than in the other heme
proteins. Yonetani demonstrated the presence of this radical and
modiﬁed his model [37,141]. In the subsequent studies [6,32,34,73],
the apparently functional complex was compared with the inactive,
yet stable ferric–ferric and ferrous–ferric Cc–CcP forms, whose
afﬁnities were determined by biophysical methods [49].
All the initial kinetic measurements were consistent with a role for
a single, ferric or ferrous Cc molecule associated with the enzyme in
the catalytic cycle [3,6,34]. In the simplest such model, the binding
and dissociation of Cc were fast processes. Therefore, the Cc(Fe2+)-
CcP complex had the character of a true Michaelis complex, whose
binding constant was numerically close to the Michaelis constant for
the overall reaction, and intracomplex ET from the bound Cc was the
rate-limiting step when all the enzyme was complexed with the
substrate Cc(Fe2+) [6,32,34,49]. The complication, not shared with
classical ‘Michaelis-type’ enzymes, was that the full catalytic cycle
involved twomolecules of Cc and two peroxidase intermediates, CpdI
and CpdII (Fig. 10).
The two ‘sides’ of the cycle are essentially symmetrical. If peroxide
is present in kinetic excess and the product dissociation is fast, the
steady state system at high levels of Cc(Fe2+) will contain equal
amounts of CpdI-Cc(Fe2+) and CpdII-Cc(Fe2+) complexes, linked by
the limiting ET rates with an ‘average’Michaelis complex as in Eq. (5):
CpdI CcðFe2þÞ↔CpdII CcðFe2þÞ ð5Þ
CcP CcðFe2þÞ þ H2O2→CpdI CcðFe2þÞ↔CpdII CcðFe2þÞ ð6Þ
If complex formationanddissociationaremuch faster than the redox
reactions, then all the CcP molecules will be associated with Cc even at
lower peroxide levels, and the initial peroxide reaction will be with the
Cc–CcP complex (Eq. (6)). If the product, Cc(Fe3+), also binds and
dissociates rapidly, an exponential, Smith-Conrad type enzyme kinetics
will be observed at all concentrations of the substrate, Cc(Fe2+), as is
usually the case [3]. For a comprehensive overview of the steady-stateFig. 10. CcP enzymatic cycle.kinetics in this system, the reader is referred to the reviewbyErman and
Vitello [7] and the recent book of Dunford [142] on catalases and
peroxidases.
4.2. “One site” model
4.2.1. Steady-state kinetics
After early enzymological studies of CcP (Section 4.1.), a number of
more recent reports [70,110,143–146] investigated steady-state
kinetics of CcP-catalysed peroxide reduction by both yCc and hCc. It
was found that, at Cc saturation and low peroxide concentrations, the
reaction between the resting-state CcP and H2O2 is governed by a
bimolecular rate constant of 35±7 μM−1 s−1, while at higher
peroxide concentrations (N200 μM) some enzyme inactivation is
observed [143]. At H2O2 saturation and low ionic strength, the initial
velocities exhibit biphasic dependence on Cc concentration
[70,144,146]. For hCc–CcP, theMichaelis constants for the two phases,
KM1 and KM2, do not correlate with the dissociation constants for two
Cc binding sites, KD1 and KD2, and, thus, cannot be interpreted in terms
of a simple two-binding site mechanism [143]. For wt yCc–CcP
complex, though, there is a good agreement between KM1, KM2 and
KD1, KD2 [70,110]. However, this agreement breaks down for W191F
CcP [145], casting doubt on the use of KM1 and KM2 as a measure of Cc
binding afﬁnity at two sites. As the determined rate constants report
on a process comprising two one-electron reduction steps each
involving Cc binding, intracomplex ET, and dissociation (Fig. 10), the
Cc–CcP steady-state kinetics are complicated and, despite promising
studies [110,147] attempting to rationalise the kobs values in terms of
these elementary steps (Section 4.2.5.), remain poorly understood [7].
4.2.2. Stopped-ﬂow kinetics
In order to obtain the individual rate constants for the reduction of
CpdI and CpdII (Eqs. (3)–(4), Section 1.3.), transient-state kinetics
were studied by stopped-ﬂow techniques [41,107,109,148–153].
Initial accounts of transient CpdI reduction by hCc and yCc at low
ionic strength reported biphasic curves, originally interpreted as
reduction of CpdI to CpdII, followed by reduction of CpdII to the
resting-state enzyme [41,148,149]. However, the second, very slow
phase was later shown to be due to small amounts of H2O2 in the
working solutions of Cc [109]. The current explanation of these
transient kinetics data is that CpdI reduction to CpdII at low ionic
strength is too fast to be resolved in the stopped-ﬂow experiment, and
the initial phase is due to the reduction of Fe(IV)=O species in CpdII
(see below).
To resolve the fast CpdI reduction phase and establish which of the
two centres, W191+• or Fe(IV)=O, is reduced ﬁrst, Hahm et al. [150]
used two stopped-ﬂow protocols: protocol A, employing an excess of
CpdI over Cc and protocol B, utilising excess of Cc. In each case,
transients at 416 nm (Cc oxidation) and 434 nm (oxyferryl reduction
at Cc isobestic point) were followed. It was shown that at CpdI excess
(protocol A), only the former is observed, indicating that Fe(IV)=O is
not reduced and Cc oxidation is entirely due to CpdI W191+•
reduction. At Cc excess (protocol B), both transients are detected,
consistent with the subsequent reduction of Fe(IV)=O in CpdII. In
protocol A, the decay curve at 416 nm is monophasic in the range of
ionic strengths tested; however, only 40% of the expected absorbance
change is detected at Ib50 mM, indicating that a large part of the
reaction at low ionic strength is too fast to be resolved in this
experiment [150]. In protocol B, a biphasic transient at 416 nm,
reporting on both CpdI and CpdII reduction steps, and a slow
monophasic decay at 434 nm, reporting on Fe(IV)=O reduction in
CpdII, are detected. Both CpdI and CpdII reduction steps are described
by bimolecular rate constants ka and kb, respectively. For hCc-CcP in
2 mM phosphate pH 7.0, ka=400–33 μM−1 s−1 and kb=30–3.5
μM−1 s−1 were measured at I=54–154 mM [150]. Based on these
results, Millett and co-workers [151] proposed the following kinetic
Fig. 11. Kinetic scheme for CpdI reduction by Cc.
Fig. 12. The Cc-Ru photocycle.
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(IV)=O) is reduced to yield CpdII containinghemeoxyferryl Fe(IV)=O
group (CpdIIF). This is followed by a rapid, pH-dependent equilibration
between two forms of CpdII and subsequent reduction of W191+•-
containing CpdII (CpdIIR) to yield the resting-state enzyme. In this
scheme, k1 and k2 are assumed to be equal, and the measured rate
constants for the two reduction steps are given by ka=k1 and
kb=k1K/(K+1) [151].
Study of the ionic strength dependence of ka and kb for yCc and hCc
oxidation at pH 7.0 [107] revealed that both rate constants increase
with decreasing I and exhibit the same slopes in log kð Þ= f
ﬃﬃ
I
p 
plots
(Fig. 2 in ref. [107]). For both cytochromes, kb is an order of magnitude
smaller than ka at any given I, and both rate constants are consistently
larger for yCc than those for hCc. Extrapolating the trends to low I
values suggests that CpdI reduction is too fast to be measured at low
ionic strength, consistent with earlier ﬁndings (see above). A later,
more detailed, stopped-ﬂow study byWang et al. [109] established that
for yCc ka varies from180 μM−1 s−1 at I=310 mM toN3,000 μM−1 s−1
at Ib100 mM, while kb exhibits a more complex behaviour. It initially
rises from 27 μM−1 s−1 at I=310 mM to 250 μM−1 s−1 at 160 mM,
then progressively slows down at Ib100 mM (Fig. 8 in ref. [109]). This
observation, together with the evidence from photo-induced ET
measurements (Section 4.2.3.), suggests that at low ionic strength
the reaction is limited by Cc(Fe3+) release from CpdII-Cc(Fe3+)
complex, implying that product dissociation in the ﬁrst reduction
step is the rate-limiting process for the subsequent Fe(IV)=O re-
duction at low I [109].
4.2.3. Photo-induced electron transfer
To address the mechanistic details of the CcP catalytic cycle,
several groups have studied photo-induced ET in Cc-CcP complex. The
idea to use photochemistry to trigger intracomplex ET in Cc–CcP
system was initially exploited by Tollin and co-workers [106,154–
157], who reported on a series of transient kinetic studies whereby
laser ﬂash photolysis is used to reduce ﬂavin to a ﬂavin semiquinone.
The latter reduces Cc(Fe3+) bound to CpdI, and intracomplex ET is
monitored. The initial study showed that ET rates to CpdI vary
signiﬁcantly among the different cytochromes used (horse, tuna and
yeast iso-2) [154]. The ET kinetics were interpreted using the Poulos
and Kraut model [81], and it was concluded that the static model
could not account for all aspects of the protein–protein interaction in
solution and, thus the kinetics reﬂected some average of ET-active
species in rapid equilibrium (i.e. a dynamic assembly). Whilst the
recognition of dynamics within the complex was with hindsight
correct, the ET rates were not in keeping with later studies. The rate
constants measured in the ﬂavin system were assumed to be for ET
within a 1:1 complex, whereby the Fe(IV)=O site of CpdI was
reduced ﬁrst [154]. This conclusion contrasts sharplywith the ﬁndings
of later stopped-ﬂow and ﬂash photolysis studies (discussed below),
demonstrating that the W191+• radical is reduced ﬁrst and at a much
faster rate. Given the low reduction potential (Eo) of ﬂavin/ﬂavin
semiquinone system (Eo≈−230 mV [154], compared to Eo=260mV
for Cc(Fe3+)/Cc(Fe2+) redox couple [10]), it appears that the reported
intramolecular ET rateswere limited by the initial reductionof Cc(Fe3+).
To overcome these limitations, Millett and co-workers developed
an alternative photo-induction scheme, harnessing favourable pho-
tochemical properties of Ru2+-bis(bipyridine) derivatives. First, Ru2+probe is covalently attached to Cc surface via a single lysine or
cysteine residue (see ref. [158] for an overview of the bioconjugation
techniques used), and the resulting modiﬁed protein (Cc-Ru) is
puriﬁed by standard chromatographic procedures [159]. Photo-
excitation of Ru2+ probe generates a strong reducing agent, Ru2+*
(Eo (Ru2+*/Ru3+)=−720 mV [159]), which can either decay to the
ground state or reduce Cc(Fe3+), generating a Ru3+-Cc(Fe2+)
intermediate (Fig. 12). The latter can either return to the ground
state by back ET from Cc(Fe2+) to Ru3+ or transfer an electron to its
redox partner such as CpdI. Addition of sacriﬁcial electron donors such
as EDTA or aniline prevents the back ET and generates ET-competent
Ru2+-Cc(Fe2+) species (protocol 1 in Fig. 12) [160,161]. Alternatively,
Ru3+-Cc(Fe2+) intermediate can oxidise W191 in the resting-state
CcP (Eo (Ru3+/Ru2+)=1.3 V [159]), thereby generating W191+•
radical (i.e. CpdIIR species) alongside the Ru2+-Cc(Fe2+) product
(protocol 2 in Fig. 12) [108]. The latter strategy allows studying
W191+• reduction in the absence of Fe(IV)=O and H2O2, normally
used to generate CpdI [108]. Depending on the attachment site, the ET
from Ru2+* to Cc(Fe3+) occurs with a rate constant k1=105-107 s−1
[159], enablingmeasurement of fast ET from Cc(Fe2+) to CpdI. Among
the main criticisms of the Ru-mediated photo-induced ET approach
are the observed variability of ET with different Cc-Ru derivatives and
a concern that steric hindrance from the introduced bulky probe, as
well as surplus positive charge imparted by Ru2+ ion, might perturb
the native Cc-CcP interaction. Nevertheless, as shown in what follows,
Cc-Ru studies of Millett and co-workers [107–109,147,152,158–163]
have provided a wealth of information on the mechanism of the
intermolecular ET in Cc-CcP system.
Photo-excitation of Cc-Ru in the presence of CpdI results in
intermolecular ET, which is reported by Cc oxidation or Fe(IV)=O
reduction and can be monitored spectrophotometrically [160],
similarly towhat is done in stopped-ﬂow experiments (Section 4.2.2.).
At all experimental conditions tested, no change in absorbance due to
Fe(IV)=O species is detected, yet Cc oxidation is observed
[107,109,152,158,160–162]. This conclusively shows that W191+• is
the primary reduction site in CpdI, in good agreementwith the stopped-
ﬂowstudiesdiscussed above. Subsequent reductionof Fe(IV)=Ocanbe
observed in multiple-ﬂash experiments [160], where re-excitation of
Cc-Ru provides additional reducing equivalents for the second ET step.
In 2 mMphosphate pH 7.0, depending upon hCc-Ru derivative, the rate
constants for the ﬁrst and second reduction processes are keta=5,200–
55,000 s−1 and ketb=110–350 s−1, respectively [161], while for yCc
modiﬁed at position 39 (yCc-Ru39) the values are keta=2·106 s−1
and ketb=5,000 s−1 [109]. The rate constant ketb for the reduction of
Fe(IV)=O reports on CpdIIF - CpdIIR conversion, followed by the
intracomplex ET fromCc2+-Ru toW191+•. Observation of faster ET in
the physiological yCc-CcP complex compared to hCc system parallels
the ﬁndings of stopped-ﬂow experiments [107]. For all hCc-Ru
derivatives, keta decreases with increasing ionic strength [161], again
in agreement with stopped-ﬂow kinetics [107], while ET rates for
yCc-Ru39 are virtually constant in I=2–100 mM range [109]. At low
ionic strength, reduction of W191+•with hCc-Ru conjugates exhibits
biphasic behaviour [107,152,161], which was taken as evidence for
the presence of multiple Cc–CcP binding forms and led the authors to
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for the slow phase is inactive in electron transfer, and the observed
rate constant is governed by the rate of conversion to the fast
orientation” [161]. Interestingly, recent PRE NMR studies have
shown that most of the Cc-CcP orientations constituting the dynamic
encounter state are ET-inactive (Fig. 9D, Section 3.2.1.), lending
support to the above hypothesis.
4.2.4. CpdIIF–CpdIIR equilibrium
Derived from the stopped-ﬂow and photo-induced ET data, the
kinetic model of Millett and co-workers (Fig. 11) postulates that
1) both ET steps take place from Cc(Fe2+) bound at the high-afﬁnity
site to W191+• group on CcP and 2) there is a fast equilibrium
between two CpdII forms, regeneratingW191+• radical for the second
ET event. Experimental veriﬁcation of these conjectures has so far
provided no unequivocal conclusions. The necessity for the ET to
proceed via W191+•, as opposed to direct ET to Fe(IV)=O, has
primarily been inferred from the results of steady-state and transient
kinetics studies [145,164], which reported a 10,000-fold decrease in
the rate of Fe(IV)=O reduction for W191F CcP compared to the wt
enzyme. Additional evidence for the pivotal role of W191+• comes
from the recent work of Goodin and co-workers [165–167], who have
excised W191-G192-A193 stretch of the proposed ET path in CcP and
reconstituted it with a synthetic (N-benzimidazole-propionic acid)-
Gly-Ala-Ala peptide (BzGAA). Despite very close structural similarity
of the native and BzGAA-reconstituted CcP, the latter is catalytically-
inactive (kcatb0.02% that of the wt enzyme) [167], highlighting the
importance ofW191+• radical for the intermolecular ET. However, the
facts that reduction of wt CcP prepared in pure Fe(IV)=O form (i.e.
CpdIIF species) generates no signiﬁcant amount of W191+• [168], and
H175Q/W191F CcP mutant exhibits considerable catalytic activity (ca.
20% that of the wt enzyme) [169] illustrate the possibility of extra-
W191 ET.
Early kinetics study of CpdI reduction by hCc(Fe2+) and [Fe(CN)6]4-
established the presence of two species: one with a “free-radical-like”
EPR spectrum (now known to be CpdIIR containing W191+•) and the
other being Fe(IV) compound responsible for the changes in the
optical spectra (CpdIIF containing heme oxyferryl group, Fe(IV)=O)
[40]. Based on the kinetic evidence alone, the authors could not
discriminate between mechanisms involving two independent bind-
ing sites or two sites in rapid equilibrium; however, for the latter case,
the equilibrium constant K=[CpdIIR]/[CpdIIF] was estimated at
different pH values and shown to vary from 1.2 at pH 5 to 0.0 at pH
8.0 [40]. A later stopped-ﬂow study by Millett and co-workers [151]
demonstrated that for hCc at I=110 mM the rate ofW191+• reduction,
ka, is virtually independent of pH, while the rate constant for Fe(IV)=O
reduction, kb, steadily decreases from 55 μM−1 s−1 at pH 5.0 to
1.5 μM−1 s−1 at pH 8.0. Similar pH dependence of ka and kb was
observed for yCc [152]. Estimates of the equilibrium constant showed
that K varies from 1.1±0.3 at pH 5.0 to≤0.05 at pH 8.0 [151,152], in
excellent agreement with the original report [40].
Interestingly, K= f(pH) dependence ﬁts well to a single ionisation
event with pKa=5.7±0.1, suggesting that the equilibrium between
CpdIIF and CpdIIR forms can be controlled by a single CcP residue
[151]. A similar pH transition was observed by steady-state kinetics
and shown to be buffer-dependent, with pKa values of 4.0 and 5.5 in
phosphate and nitrate, respectively [170–172]. The CcP heme
environment contains three titratable groups: D235, located at the
proximal side and hydrogen bonded to W191 and heme ligand H175
(Fig. 4), and H52 and R48 residues found in the distal heme pocket.
The steady-state kinetics of the wt and D235N CcP exhibit similar pH
dependence, which rules out D235 as the source of the observed
ionisation event [173]. Study of R48L and R48K CcPmutants suggested
that R48 sidechain contributes to destabilisation of the protonated
form of H52 and binds nitrate, explaining the observed buffer-
dependence [174]. Finally, analysis of H52L CcP identiﬁed H52 residueas the group associated with the low pH transition and playing a
critical role in CpdI stabilisation [172]. Given the similarity of the pKa
values obtained from the steady-state [170–172] and transient [151]
kinetics, it is plausible that the ionisation status of H52 also governs
the CpdIIF–CpdIIR equilibrium. Experimental study of the ET proper-
ties of CpdII in H52-substituted CcP variants could provide a means to
verify this hypothesis.
Using stopped-ﬂow kinetics and photo-induced Cc-Ru ET, Liu et al.
[152] measured the exchange rate between two CpdII forms. To
observe intramolecular ET in CpdII, the authors had to ﬁnd conditions
under which reduction of W191+• in CpdI is much faster than the rate
of the subsequent Fe(IV)=O to W191+• conversion. This was
achieved by lowering the pH, thereby shifting the CpdIIF–CpdIIR
equilibrium to the right. Another way to affect this equilibrium was
offered by substituting M230 CcP residue thought to stabiliseW191+•
radical. Thus, it was shown that theM230Imutation had little effect on
CpdIW191+• reduction, yet impaired intramolecular ET to Fe(IV)=O,
signiﬁcantly decreasing the rate of CpdII reduction [152]. For the wt
CcP, the CpdIIF–CpdIIR exchange rate constant, kFR, was measured at
pH 5.0 (kFR=1,100 s-1) and pH 6.0 (kFR=600 s−1). Though being
higher than earlier estimates obtained at pH 7.0–7.5 [41,168,175], the
obtained kFR values were argued to be too slow to account for the
results of this and earlier works [40,152]. A possible explanation for
this discrepancy, yet to be tested experimentally, is that conversion
from CpdIIF to CpdIIR occurs only in the transition state, with possible
stabilisation of W191+• radical [168].
If the transition from CpdIIF to CpdIIR is the rate-limiting process in
CpdIIF reduction, the rate constant for the second ET step, ketb, should be
the same for all Cc-Ru conjugates exhibiting fast reduction of W191+•
(i.e. large keta) and remain approximately equal to the CpdIIF–CpdIIR
conversion rate, kFR,on≈500 s−1 estimated at pH 7.0 [109]. However,
ketb values for hCc-Ru vary from 110 to 350 s−1 [161] and are slightly
lower than the kFR,on estimate, suggesting that another process must
limit the rate of Fe(IV)=O reduction under these experimental
conditions (see Section 4.2.5.). For yCc-Ru39, ketb=5,000 s−1 [109] is
an order of magnitude higher than kFR,on value, which is inconsistent
with the simple kinetic scheme proposed earlier (Fig. 11). In order to
resolve this discrepancy,Millett and co-workers [109] presented amore
detailed mechanism of CpdIIF reduction, taking into account Cc binding
and dissociation events (Fig. 13).
The reduction of the heme oxyferryl group in CpdIIF proceeds via
multiple steps, starting from A and leading to the product H. For
simplicity's sake, the rates of Cc association (kf) and dissociation
(kd) are assumed to be independent of Cc and CcP redox states [109].
Transition from CpdIIF to CpdIIR includes internal ET to W191 group
(denoted by R) and formation of Fe(III)-O- intermediate C, which is
converted to F (CpdIIR) via hydrogen transfer and concomitant
water release (C-F step). The same sequence of events (steps B-G)
takes place in CpdIIF complex with Cc(Fe2+). The exchange constant
between A and F (and, by analogy, B and G) is given by kFR,
determined experimentally by Liu et al. [152]. Under the conditions
where Cc(Fe2+) binding is rate-limiting (such as those in the
studies of hCc-Ru derivatives [152,161], which used small
Cc concentrations and a single equivalent or excess of CpdI), Fe
(IV)=O reduction follows A-C-F-G-H pathway. In this case, the rate
constant ketb includes the contributions from CpdIIF–CpdIIR con-
version (steps A-C-F) and Cc binding (step F-G) steps. Under
saturating Cc(Fe2+) conditions (such as those in the study of Wang
et al. [109], employing excess yCc-Ru39 over CpdI), B-D-G-H or B-D-
E-H paths will be followed. According to Wang et al. [109], the latter
pathway is strongly favoured as ET fromCc(Fe2+) toW191+• is faster in
D-E thanG-Hstepdue to chargeneutralisation ofW191+• radical-cation
by Fe(III)-O- species [109]. In this case, the rate of the intracomplexET to
Fe(IV)=O is no longer limited by kFR, but is given instead by
ketb=keta·KDB/(1+KDB), where KDB=[D]/[B], which explains the
large observed ketb=5,000 s−1 [109].
Fig. 13. Kinetic mechanism of CpdII reduction.
Fig. 14. The Zn-porphyrin photocycle for a 1:1 complex between ZnCcP and Cc.
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The ﬁnal aspect of the “one-site” ET model concerns the role of the
low-afﬁnity Cc binding site, known to contribute to Cc–CcP interac-
tion at low ionic strength (Section 2.2.). To address this issue, Millett
and co-workers studied the interaction of Cc(Fe2+) with the pre-
formed CpdI-Cc(Fe3+) complex at low ionic strength by photo-
induced ET kinetics [162] and stopped-ﬂow spectroscopy [153]. The
authors found no evidence for ET from Cc bound at the low-afﬁnity
site, yet observed that the dissociation rate constant of Cc bound to
the high-afﬁnity site, kd, increases from kdb5 s−1 in the 1:1 complex
to kd=600 s−1 (I=4 mM [162]) or kdN2,000 s−1 (I=10 mM [153])
upon binding of the second Cc molecule. The value of kdb5 s−1 is
smaller than kd=180 s−1 obtained at I=10 mM in the NMR study of
Yi et al. [58], possibly due to the contribution from 2:1 complex,
unaccounted for in the NMR work [162]. At IN74 mM the effect of the
second Cc binding event is no longer measurable [162], consistent
with observed destabilisation of the 2:1 complex at high ionic
strength (Section 2.2.). These ﬁndings conﬁrmed the “substrate-
assisted product dissociation” model proposed before [58,106,127]
and suggested that ”… the rate-limiting step in enzyme turnover is
product dissociation below 150 mM ionic strength, and intracomplex
electron transfer to the oxyferryl heme above 150 mM ionic strength.”
[162].
The latter conclusionwas corroborated by the steady-state kinetics
work of Miller et al. [110,147], who showed that the change in the
ionic strength dependence of kcat and the deviation from hyperbolic
kinetics at Ib110 mM are caused by a change in the rate-limiting step
and established that at Ib110 mM the enzyme turnover is limited by
Cc-CcP dissociation. At low ionic strength, a simple scheme assuming
only 1:1 complex formation cannot account for the observed kinetics
with kcatNkd. Thus, to take into account the contribution of Cc
molecule bound at the low-afﬁnity site, Miller [110] performed
numerical simulations of the kinetic model containing 1:1 and 2:1 Cc-
CcP complexes using the published values for the elementary reaction
steps (Fig. 13). The developed model predicts enzyme turnover rates
at the high-afﬁnity binding site and reproduces the experimentally
observed ionic strength dependence of kcat. In agreement with the
results of Millet et al. [153,162], Cc bound at the low afﬁnity site is
shown to be ET-inactive [110], suggesting that “The existence of this
unreactive binding site is probably serendipitous, since it does not
contribute to catalysis at physiological ionic strength.” [147].
From the above kinetic evidence, the “one-site” ET model can be
summarised as follows. Both reduction steps involve ET fromCc bound
at the high-afﬁnity, crystallographic site toW191+• of CcP. There is no
direct ET to Fe(IV)=O, but rather fast equilibration between CpdIIF
and CpdIIR, regenerating W191+• for the second reduction step. Cc
bound at the low-afﬁnity site exhibits no ET activity, but enhances
dissociation of Cc bound at the high-afﬁnity site. Cc dissociation after
the ﬁrst ET event or the subsequent CpdIIF–CpdIIR conversion is the
rate-limiting step for CpdI reduction at the low andhigh ionic strength,
respectively.4.3. “Two-sites” model
It was demonstrated that under some experimental conditions,
especially low ionic strength, CcP catalysis exhibits biphasic behaviour
with respect to Cc concentration [33,70], which presented one of the
earliest complications in the analysis of the kinetic curves. Kang et al.
[33] analysed the data as simply involving two independent, equally
accessible sites, perhaps associated with the heme oxyferryl and
radical species, leading to the ﬁrst proposal of a 2:1 Cc–CcP
stoichiometry. Soon after that, Erman and co-workers [70] interpreted
similar data in terms of a single binding site, but with two distinct Cc
reactions and, hence, purely kinetic biphasicity; yet later they found
that either explanation could account for the results [143].
Hoffman and co-workers have presented the most compelling
evidence for an ET-active 2:1 complex in a series of studies exploiting
the photochemistry of Zn-porphyrins [43–45,176]. The authors showed
that intermolecular ET in Cc-ZnCcP complex can be studied by
substituting the heme in either CcP or Cc with a Zn-porphyrin (ZnP)
and phototriggering its redox chemistry [9]. Fig. 14 illustrates an ET cycle
for ZnCcP bound in a 1:1 complex with Cc. Photo-excitation of the
ground-state ZnCcP leads to the formation of a triplet state, 3ZnCcP,
which in the absenceof Cc(Fe3+) returns to theground statewithadecay
rate (kD) of ~120 s−1 [43]. When bound to Cc(Fe3+), 3ZnCcP can either
decaydirectly to theground statewitha rate constant (kD+ko),whereko
is the rate of non-redox quenching, or undergo an intermolecular,
forward ET with a rate constant kf to yield a charge-separated
intermediate, I (D+A-). The latter returns to the ground state via a back
ET from the bound Cc(Fe2+) to the ZnP-based π-cation radical (ZnP+)
with a rate constant kb (Fig. 14). TheZnP systemdiffers fromtheCc-RuET
setup (Section 4.2.3) in that the photo-initiated ET event proceeds in a
non-physiological direction, i.e. from CcP to Cc. However, the back ET
reaction mirrors the physiological ﬂow of electrons from Cc(Fe2+) to
CpdII. Early criticisms of this approach raised concerns that back ET
occurs directly between two heme groups, bypassing formation of
W191+• species and, thus, is non-physiological [7,147,153,162]. More-
over, despite the formal equivalence of the two processes, the kinetics of
Cc(Fe3+) reduction by 3ZnCcP and CcP(Fe2+) are different, suggesting
that ZnP substitution perturbs the native Cc-CcP interaction [7].
Titrating ZnCcP with Cc from several species – hCc and fungal Cc
(fCc) from Candida krusei, Pichia membranefaciens, or iso-1 form from
S. cerevisiae – Stemp and Hoffman [43] observed that the quenching
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should be saturated with Cc if the binding was 1:1. In the case of fCc, it
was found that the intermediate species I did not accumulate until the
second Cc molecule was bound. This was taken as an evidence for the
ET-inactive 1:1 complex, with the observed quenching entirely due to
a non-redox process (i.e. kq=ko), and suggested that the ET takes
place only at the second binding site on CcP [43]. The latter conclusion
was reinforced by the observation that increasing the ionic strength
eliminates the quenching attributed to ET, consistent with disruption
of a reactive, electrostatic 2:1 Cc-CcP complex. A slightly different
scenario was observed for hCc. A build up of I occurred at the 1:1
stoichiometry and rose synchronously with kq upon binding of the
second hCc molecule. The 2:1 stoichiometry was thus inferred but, in
contrast to fCc complexes, both binding sites on CcP were ET-active,
with the second site being more ET efﬁcient [43]. The quenching
titrations were also used to obtain binding constants for Cc(Fe3+)-
ZnCcP complexes. At low ionic strength, the ﬁrst Cc binds tightly
(Kdb1 μM), followed by a weaker binding of the second molecule
(KdN100 μM). Moreover, it was shown [43] that dissociation rate
constants, koff, of both ferrous and ferric Cc from the second binding
site are highly sensitive to the ionic strength and koff(Cc(Fe2+))bb koff
(Cc(Fe3+)), consistent with release of the product, Cc(Fe3+), during
the catalytic cycle and a higher afﬁnity for the substrate, Cc(Fe2+).
An inverse titration was also reported, whereby quenching of the
photo-initiated triplet state of ZnP-substituted hCc (3ZnCc) with
resting-state CcP(Fe3+) was monitored [44]. The kq was found to
increase up to [CcP]/[ZnCc]=1:2 and then decrease with further
addition of CcP(Fe3+) quencher [44]. These results were consistent
with two Cc molecules binding simultaneously, and the ET quenching
being much more efﬁcient in a 2:1 complex. By way of a further
variation to this system, Hoffman and co-workers introduced a
reverse protocol, whereby the quencher was held at a ﬁxed
concentration and the photo-excitable ZnP probe titrated [45]. The
results from this study again compounded the 2:1 stoichiometry of
the complex at low ionic strength. The ﬁndings of detailed
photochemical studies of Hoffman and co-workers were summarised
in a following model [9]. At Cc : CcP ratios of N1, a second distinct
binding site is required to explain the quenching data, with binding
afﬁnity to the Site 2 being lower than that to Site 1 by a factor of 1,000.
For the CcP complexes with fCc, the quenching data are consistent
with ET activity occurring only at Site 2, whereas hCc–CcP complex
exhibits ET at both sites, but ca. 1000 times faster at Site 2 under low
ionic strength conditions.
The binding of two Cc molecules to CcP, and the notion that ET
took place predominately at Site 2 in the physiological complex, raised
further questions about the interplay between bound Cc molecules
and ET in the complex. These were addressed by the introduction of a
copper-substituted Cc, Cc(Cu2+), into the ZnP ET photocycle [176].
This redox-inert inhibitor was designed to examine the ‘back’ ET step
(kb) and probe cooperativity between Cc molecules, i.e. whether Cc
bound at the high-afﬁnity site enhances ET activity at Site 2 [176].
Back ET displayed multiphasic kinetics, which was suggested to be
due to gating by conformational interconversion [43,177,178]. As ET
occurs predominately in the 2:1 complex, this means that the charge-
separated intermediate I has the 2:1 stoichiometry [ZnP+CcP:Cc(Fe2+):
Cc(Fe3+)]. The possibility therefore existed that the complex kinetics
describing the back reaction could be due to an electron self-exchange
between Ccmolecules bound to the surface of ZnCcP before ZnP+CcP is
reduced. The results from a series of quenching experiments –
performed with fungal Cc(Cu2+), a close mimic of yCc – resoundingly
disfavoured a cooperative ET process and eliminated the possibility of
electron self-exchange between bound Cc molecules [176].
The ZnP system pioneered by Hoffman and co-workers to study ET
between Cc and CcP in solution has also been used in the solid state.
Single crystals of ZnCcP complexes with yCc and hCc were grown, and
quenching of the 3ZnCcP triplet excited state by Cc(Fe3+) and Cc(Fe2+)measured [96]. The kf quenching rates agree very well with the values
obtained in the solution studies [43]. This strongly indicates that the
crystal structures represent the associations of both yCc and hCc that
determine ET reactivity under low ionic strength and protein concen-
trations in solution. The quenching rates for the multiphasic back
reaction, kb, in hCc–ZnCcP complex are slightly increased compared to
solution values, suggesting that a reducedmotion in the lattice favours a
more active ET conformation [96]. For the yCc–ZnCcP, the back ET in the
crystal was too fast tomeasure, and no charge-separated intermediate I
was observed. Thismirrors the results of solution studies,wheremost of
I arises frombinding of yCcmolecule at the second site [43],which is not
accessed in the crystal. Theoretical calculations of ET tunnelling rates
obtained from the static X-ray structures of CcP complexeswith yCc and
hCc [42] revealed that the intermolecular ET is many orders of
magnitude faster for the physiological yeast complex [9]. Although the
observed high kb values, especially those for yCc–CcP complex, agree
with the theory and rationalise the absence of an observable
intermediate I, the forward rate is only ﬁve times greater for yCc–CcP
than hCc–CcP, despite very different association modes in the two
complexes (Fig. 6). This led Kang et al. [96] to suggest that small
conformational ﬂuctuations in the interface of the complex are
responsible for governing the kf and, once a productive conformation
‘locks in’, the rates are fast enough to be controlled by a coupling
pathway, such as that proposed for yCc–CcP (Fig. 6D).
The same authors addressed the effects of interface mutations on
Cc–CcP binding orientations and ET through site-directed mutagen-
esis of yCc residue F82 and subsequent study of themutant complexes
by ZnCcP triplet-state quenching in single crystals [98]. F82
contributes only 13 A2 of buried surface area to the Cc–CcP binding
interface, yet, surprisingly, it was found that several substitutions of
this residue led to completely different binding geometries [98]. The
ﬁndings of this study support the proposal of Stemp and Hoffman [43]
that Site 1 on CcP is dynamic, enabling a number of Cc association
modes with similar ET activity, the conformational ﬂuctuations
among which enable efﬁcient intracomplex ET [98].
Finally in this section we return again to solution studies. A recent
work by Hoffman and co-workers [179] addressed an earlier issue
relating to the use of ZnCcP and the assumption that I returns to the
ground state by direct ET between the two hemes (kb step in Fig. 14).
The ZnP+ species of I is potentially able to oxidiseW191, which opens
the possibility of a two-step, “hopping” return to the ground state as
indicated in Fig. 14 (kw path). Seifert et al. [179] showed that kb in
W191F CcP–yCc is much slower compared to that in the wt 1:1
complex. In themutant complex, the population of I steadily increases
up to a 1:1 Cc-CcP ratio, contrasting sharply with the ﬁndings for the
wt complex, where I is not observed at equimolar protein ratio either
in solution [43] or the crystalline state [96]. The W191F CcP mutant
cannot be oxidised by ZnP+, hence the return to the ground state is
slow, allowing I to accumulate [179]. From this study it is clear that
W191 does have a role in the ZnCcP system: it acts as an ET mediator
“short circuiting” the direct heme-to-heme ET through a two step
“hopping” process (Fig. 14). In the case of hCc, the observation of I in
both solution and the crystal at 1:1 stoichiometry suggests that kw is
decreased with respect to the optimally coupled yCc–CcP complex.
4.4. Electron transfer in covalently cross-linked complexes
Study of the ET in covalent Cc-CcP complexes offers a way to
address the functional properties of low- and high-afﬁnity Cc binding
sites one at a time, without complications arising from Cc interaction
at the other site. In particular, cross-linking Cc with CcP allows
blocking one Cc binding site, while leaving the other one free to
interact with an exogenously added Cc. Early cross-linking efforts
(discussed in detail in Section 2.3.1.) were complicated by heteroge-
neity of the products, ambiguity of the cross-linking sites, and possible
inactivation of the resulting covalent complexes by an excess of a
Table 3
Thermodynamic parameters for Cc binding to the high-afﬁnity site on CcP. ΔH and -TΔS
(in kcal/mol) were obtained by ITC. Note a good agreement among the values obtained
from different studies.
Cc ΔH -TΔS Conditions and reference
hCc 2.8±0.8 −10.9±0.3 pH 6.0 I=20 mM 26 °C [60]
hCc 2.7±0.3 −10.9±0.6 pH 7.0 I=18 mM 25 °C [63]
yCca −6.2±0.3 −1.9±0.4 pH 6.0 I=20 mM 25 °C [62]
yCc −2.6±0.1 −5.5±0.1 pH 6.0 I=20 mM 25 °C [64]
yCc −2.3±0.4 −5.3±0.5 pH 6.0 I=20 mM 25 °C [65]
yCc −1.6±0.1 −5.7±0.2 pH 6.0 I=115 mM 30 °C [66]
a K72 is trimethylated. Removing the methyl groups increases ΔH by 3.6±
0.1 kcal/mol, but, due to enthalpy-entropy compensation, has no effect on ΔG [64].
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a cross-linker at speciﬁc residues, uncertainty of the corresponding
attachment site on CcP often precluded the unequivocal interpreta-
tion of the kinetics data [146]. Perhaps the most conclusive study of
this kind was performed by Bisson and Capaldi [83], who showed that
K13 Cc–CcP cross-link was inactive towards exogenously added Cc,
suggesting that functionally-active Cc binding site is blocked in the
covalent complex.
In a conceptual breakthrough obviating most of the earlier
problems, Poulos and co-workers [180,181] prepared several homog-
enous cross-links, covalently coupled via an intermolecular disulﬁde
bond between single-cysteine Cc and CcP variants. Three covalent
complexes were prepared: Complex I (C102 Cc–E290C CcP), with
‘back-to-front’ Cc–CcP coupling; Complex II (K73C Cc–E290C CcP),
mimicking the crystallographic binding geometry; and Complex III
(K79C Cc–K149C CcP), targeting the putative low-afﬁnity Cc binding
site. Complex I showed no ET from the covalently linked Cc, most
likely due to a large separation between the redox centres, while
Complex II exhibited fast intramolecular ET with a lower limit of
800 s−1 [180]. Moreover, it was demonstrated that W191F CcP
mutation leads to a 1000-fold decrease in the intramolecular ET rate of
the Complex II, suggesting that the ET proceeds via reduction of
W191+• in CpdI [181]. In addition, Complex II was inactive towards
exogenously added yCc and hCc at high ionic strength and protein
concentrations, but restored the wt catalytic activity at a decreased
yCc concentration and low ionic strength [181]. At the same time,
Complex III showed virtually no ET between the cross-linked Cc and
CcP, but remained catalytically active towards the exogenously added
cytochromes, indicating that the blocked Cc binding site is not
functionally important [181].
In a follow-up work, Guo et al. [97] studied an alternative Complex
II (A81C Cc–V197C CcP) by X-ray crystallography, stopped-ﬂow
spectroscopy, and steady-state kinetics. With an rmsd of 2.82 Å
between Cα atoms of the Cc molecules (Table 2), the cross-link closely
resembles the non-covalent complex. The intramolecular ET in this
system is as fast as in the native complex (nearly complete within the
dead time of the instrument, ca. 2 ms), while the oxidation of the
exogenously added Cc is very slow (t1/2~2 min) [97]. These results
demonstrated the presence of a single, ET-competent Cc binding site
on the surface of CcP, in agreement with earlier work [180,181]. A
recent theoretical study showed that although the ET pathway
between the cross-linked proteins (with the sulphur atom of Cc
A81C acting as an effective coupling bridge) is different from that of
the wt, non-covalent complex, the overall ET rate is not affected [182],
in agreement with the above experimental ﬁndings.
A recent, meticulous analysis of the Cc–CcP cross-linking by Erman
and co-workers [183] showed that a residual activity of Complex II
towards exogenously added Cc is caused by small amounts of free CcP,
which co-puriﬁes with the covalent complex. When the latter is re-
puriﬁed by an ion-exchange chromatography, a turnover ofb0.3 s−1
(or 0.06% that of the wt CcP under the same experimental conditions)
is observed [183]. This work highlights the importance of adequate
puriﬁcation procedures for subsequent kinetics analysis and brings
into question the activity measurements for covalent complexes
reported before [87,88,97,146,181]. For example, a careful inspection
of SDS-PAGE data of Guo et al. [97] reveals a likely presence of
unreacted CcP in the cross-linked sample (faint band in lane 2, Fig. 1A
of ref. [97]), which could explain the observed residual activity of the
covalent complex towards the exogenously added Cc.
Finally, Nakani et al. [184] prepared four more disulﬁde cross-links
(Cc K79C with V5C, K12C, N78C, and K264C CcP), designed to probe a
wider CcP surface outside the crystallographic binding site. The
catalytic activities of all four constructs towards exogenously added
Cc were similar to those of the native complex, conﬁrming the
presence of a single ET-competent binding geometry — that observed
in the crystal structure. Furthermore, detailed analysis of the ionic-strength dependence of the steady-state kinetic parameters for Cc
K79C–V5C CcP cross-link revealed strong electrostatic repulsion
between the covalently-attached Cc and the Cc molecule non-
covalently bound to the high-afﬁnity site at low ionic strength [184].
5. Species-speciﬁc differences in Cc–CcP interaction
As mentioned above (Section 2.1.), yCc binding to CcP is stronger
than that of hCc in a broad range of experimental conditions.
Numerous ITC studies [60–66] have shown that hCc–CcP and yCc–
CcP complexes exhibit markedly different binding thermodynamics
(Table 3 and Fig. 15). The former is characterised by an unfavourable
enthalpy (ΔH) and large, favourable entropy term (−TΔS), while the
latter is driven by favourable enthalpic and entropic contributions.
Binding enthalpy of hCc–CcP complex changes little in the range of
temperatures studied [60], while ΔH of yCc–CcP shows a clear
temperature dependence [62]. Given that binding constants of both
complexes are virtually temperature-independent [46,60,62], this
reveals a strong enthalpy-entropy compensation in yCc–CcP, but not
hCc-CcP, interaction. Furthermore, comparison of the heat capacity
changes (ΔCp=dΔH/dT) in hCc-CcP (ΔCp≈0 [60]) and yCc–CcP
(ΔCp=−216±62 cal·mol−1·K−1 [62]) complexes – and the fact
that yCc binding to CcP shows ΔCpb0 and ΔSN0, a signature of the
hydrophobic effect [185] – indicates that the hydration properties of
the two interfaces are different, with likely larger desolvation in yCc–
CcP complex.
The ionic strength dependence of the thermodynamic parameters
is also different for the two complexes (Fig. 15). For hCc–CcP, ΔH is
virtually independent of I, while -TΔS steadily decreases with
increasing salt concentration. In contrast, both thermodynamic
parameters of yCc–CcP are highly sensitive to I, exhibiting opposing
trends indicative of enthalpy-entropy compensation. As a conse-
quence, the hCc–CcP binding constant shows stronger ionic strength
dependence than that of yCc–CcP (Fig. 15, top panel), in agreement
with an early steady-state kinetics work [33]. Another remarkable
difference in salt sensitivity of the two complexes is illustrated by
steady-state and stopped-ﬂow kinetics studies [110,143,149], show-
ing that hCc–CcP is more active at low ionic strength, while the
opposite is true for yCc–CcP (see Tables 6 and 7 in ref. [7]).
Another set of species-speciﬁc differences in Cc–CcP interaction
has been revealed by NMR spectroscopy. It was shown that Cc
binding to CcP can be conveniently monitored by spectral changes
of hyperﬁne-shifted heme resonances of both proteins [55–
58,69,93] and, with the advent of isotope labelling techniques,
chemical shift perturbations of the backbone amide nuclei of Cc
[59]. With characteristic, strong resonances located outside of the
diamagnetic envelope, Cc heme methyls 3 and 8 have proven to be
particularly useful probes. In the entire range of solution conditions
and protein concentrations tested, heme methyls of hCc exhibit a
single set of resonances that change their position upon binding to
CcP, indicating that free and bound proteins are in fast exchange on
Fig. 15. Thermodynamic binding parameters for CcP complexes with hCc (open
symbols) and yCc (ﬁlled symbols) as a function of ionic strength. Bottom panel: ΔH and
-TΔS are shown as circles and squares, respectively; lines connecting the data points
used only to guide the eye. Top panel: solid lines are linear ﬁts of the data for hCc–CcP
(r2=0.993, slope 0.57) and yCc–CcP (r2=0.974, slope 0.34). The plotted values were
obtained by ITC at pH 6.0 and 25–26 °C [60,62].
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dissociation rate constant of hCc–CcP complex was estimated from
binding-induced chemical shift perturbations5 at koff ≫200 s−1
[55] and later corrected to koffN1133±120 s−1 [56]. In contrast to
hCc–CcP, the exchange regime of yCc–CcP binding depends on
experimental conditions [186], with high temperature, ionic
strength, and protein concentration promoting fast exchange
and koff values varying from 180 s−1 at low ionic strength [58]
to N1200 s−1 at higher salt concentrations [59]. The slow-to-
intermediate exchange observed in diluted protein solutions at low
I is manifested by two sets of heme methyl resonances — those of
free and CcP-bound yCc [57,58,93,186]. However, as explained by
Moench et al. [93], the difference in exchange behaviour of hCc and
yCc does not necessarily reﬂect the difference in the corresponding
dissociation constants, but rather stems from larger binding shifts
of yCc.6
NMR chemical shift perturbations (Δδ) of yCc resonances by
binding to CcP are larger than those of hCc [57,93]. In fact, the Δδ
values for hCc in complex with CcP are similar to those induced by salt
[93,187] or binding of polyglutamate [188], suggesting low speciﬁcity
of hCc–CcP interaction. Given a good correlation between the Δδ size
and the population of the dominant protein–protein orientation in
Cc–CcP complexes [101], smaller Δδ values suggest that hCc–CcP is
more dynamic than yCc–CcP. This ﬁnding agrees well with the results
of hydrogen-deuterium exchange experiments [129,130] (see Sec-
tion 3.2.), which showed smaller protection factors for hCc–CcP than
yCc–CcP complex, and FRET work of McLendon et al. [127], who
observed a broader distribution of heme-to-heme distances in hCc-
CcP system, implying its higher mobility.
However, in their studies of covalently cross-linked Cc–CcP
complexes, Erman and co-workers [91,93] found that cross-linking5 The lower limit of koff can be calculated as koff≫
ﬃﬃﬃ
2
p
πΔδmax = 2, where Δδmax is the
maximal observed binding shift in Hz [208].
6 NMR exchange regime is deﬁned by the exchange constant (kex) and the
difference in the chemical shifts between free and bound forms (Δδ) as fast (kex≫Δδ),
slow (kex≪Δδ), or intermediate (kex≈Δδ).yCc and CcP produces a heterogeneous mixture of 1:1 adducts, while
reaction between hCc and CcP yields a single covalent product, with
an NMR spectrum highly similar to that of the native, non-covalent
hCc–CcP complex. This seems to suggest that yCc interaction with CcP
is more dynamic than that of hCc — a ﬁnding which is difﬁcult to
rationalise given the above evidence to the contrary.
X-ray crystallographic analyses [42,96] have established that yCc–
CcP and hCc–CcP adopt different binding geometries in the crystal
(Fig. 6). In order to verify whether these structural differences are
preserved in solution, Miller et al. [147] prepared A193C/C128A CcP
variant modiﬁed with a bulky thiol reagent, which would block
crystallographic binding site of yCc, but not perturb that of hCc. The
authors observed a large, 20 to 100-fold decrease in transient and
steady-state ET rates for yCc reaction with the modiﬁed CcP, but only
minor effects for hCc, whereby conﬁrming the similarity of the
crystallographic and solution Cc–CcP structures. Moreover, the rate
constant for the ﬁrst ET step in modiﬁed yCc–CcP system is similar to
that in the native, unmodiﬁed hCc–CcP complex [147], suggesting that
the introduced steric substituent steers yCc away from its crystallo-
graphic binding site and into a binding orientation similar to that
observed in hCc–CcP X-ray structure.
Using Ru-labelled Cc derivatives to study photo-induced ET to
CcP, Millett and co-workers [163] demonstrated that, at low ionic
strength, structural differences between hCc–CcP and yCc–CcP
complexes have clear functional implications: the ET in hCc–CcP,
but not in yCc–CcP system, is “gated” by conformational dynamics
of protein molecules. Based on their experimental evidence, the
authors proposed that hCc–CcP complex consists of a major, ET-
inactive form (ca. 90%) and a minor form (ca. 10%) favouring fast ET,
and that the conformational change between the two forms is the
rate-limiting step in ET process. Furthermore, the authors sug-
gested that the major and minor forms correspond, respectively, to
crystallographic hCc–CcP and yCc–CcP binding geometries [163],
implying that hCc must undergo rotational and translational motion
relative to CcP in order to adopt an ET-active conformation. Another
study fromMillett's group [107] showed that, at high ionic strength,
CcP mutations designed to probe the crystallographic yCc–CcP
binding site have the same effect on ET kinetics of both yCc and hCc
complexes, suggesting that the ET-active yCc–CcP and hCc–CcP
forms are the same. Given that both hCc–CcP structures reported so
far [42,96] have been solved at low ionic strength, independent
veriﬁcation of this hypothesis must await hCc–CcP structure
determination at a high salt concentration.
6. Physiological role of Cc–CcP complex
Based on the catalytic activity of Cc–CcP complex in vitro, it was
proposed that it acts as an antioxidant, peroxide-scavenging system in
vivo [189], and a later study conﬁrmed the role of CcP as a general
catalyst for H2O2 reduction in aerobic yeast mitochondria [190].
Recently it was shown that CcP is not essential for viability and
respiration in S. cerevisiae [191,192], yet it contributes to the
resistance against exogenous oxidative stress in vivo [193–195], and
its expression level is increased in aerobic conditions [191]. The fact
that haploid yeast cells deﬁcient in CcP (ccp1Δ) are able to sustain
aerobic metabolism [191,192] suggests a compensatory role of other
antioxidant enzymes such as superoxide dismutase, catalase, and
glutathione reductase in mitigating the oxidative stress associated
with aerobic respiration [192]. In addition to, and independent of, its
antioxidant activity, CcP participates in oxidative stress signalling
[192,193,196] and appears to be part of a complex cellular defence
network against the reactive oxygen species (ROS) [192,196]. An in
vivo study showed that, just like in S. cerevisiae, CcP contributes to the
resistance against ROS in a fungus Cryptococcus neoformans [197]. This
ﬁnding suggests that the physiological function of Cc–CcP complex is
not unique to yeast and, considering the high conservation of
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[10,197], might be a general feature of eukaryotic response to ROS.
Interestingly, recent clinical studies have shown that CcP-containing
eye drops signiﬁcantly accelerate corneal epithelial healing after
phototherapeutic keratectomy in mice [198,199]. Presumably, CcP
mitigates wound healing by neutralising elevated levels of ROS
associated with local inﬂammatory responses [199]. Finally,
another recent work has demonstrated that, in addition to its
antioxidant function, Cc-CcP couple is involved in electron shuttling
in the mitochondrial intermembrane space [200]. It was shown that
a ﬂavin-dependent sulfhydryl oxidase, Erv1, reduces Cc and utilises
molecular oxygen as an electron acceptor to generate hydrogen
peroxide, which is subsequently reduced to water by CcP using
reducing equivalents provided by Erv1-reduced Cc. Thus, Cc acts as
an electron shuttle between Erv1 and CcP, effectively coupling the
two redox cycles [200].7. The end of the road?
During the past seventy years (Fig. 1), the Cc–CcP complex has
been extensively characterised by a range of biochemical and
biophysical techniques and become a paradigm for the study of
transient protein interactions and long-range, biological ET. The
trophy cabinet of this complex features X-ray and solution Cc–CcP
structures, experimentalmap of the conformational space explored by
the interacting proteins, biophysical characterization of Cc binding to
the low-afﬁnity site, and a working kinetic model, explaining most of
the catalytic properties. After seven decades of research and hundreds
of papers written on the subject, what is left to discover in this – ad
nauseam studied for some, fascinating for others – system? Below we
outline several unknowns that are likely to shape Cc–CcP research in
the coming years.
Most of the structural and biophysical studies have been
performed on Cc(Fe2+)-CcP(Fe3+) and Cc(Fe3+)-CcP(Fe3+) systems,
corresponding to the initial association and ﬁnal dissociation
complexes, respectively (Fig. 10). In addition, CcP-CN was used as
CpdI surrogate, mimicking its spin and coordination states. However,
the question remains whether these structural mimics are represen-
tative of the transient Cc(Fe2+)-CpdI and Cc(Fe2+)-CpdII species
active during the enzyme turnover. As X-ray structures of CpdI
[201–203] and CpdIIF [203] are virtually identical to that of the
resting-state enzyme, and considering that CcP heme group is buried,
minimising the electrostatic effects of Fe(IV)=O andW191+• centres
on Cc binding, such an assumption appears sound, albeit experimen-
tally unproven.
Despite the progress made in the study of the low-afﬁnity binding
site (Sections 2.2. and 2.3.4.), the weak, salt-sensitive 2:1 Cc–CcP
complex has so far resisted unequivocal structural characterization.
Although this is not integral to understanding the Cc–CcP catalytic and
binding properties under the physiologically-relevant (high ionic
strength) solution conditions, the Cc–CcP story is by no means
complete without the structure of the 2:1 complex.
The best working model, dubbed here “one-site ET” (Section 4.2.),
accounts for most of the ﬁndings obtained by steady-state and
transient kinetics and is consistent with numerous structural and
biophysical studies. However, the obligatory role of W191+• in the
reduction of Fe(IV)=O site in CpdII and the underlying rapid CpdIIF–
CpdIIR equilibrium are still controversial issues (Section 4.2.4.). Thus,
the possibility of alternative ET pathways, not involving W191+•
centre, remains open. Using a combination of site-directed mutagen-
esis and kinetics techniques [23,25,151], it was shown that CcP
residues Y39, Y42, W51, M172, H181, W223, and Y229 are not
involved in intermolecular ET from Cc, which leaves a number of other
methionine and tyrosines residues as suitable candidates for a
transient radical location.Acknowledgements
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